Publications
Publications: Articles
1. Vaughan ED Jr, Sawyers JL, Scott WH, Jr: The Rapunzel syndrome: An unusual complication of intestinal bezoar. Surg. #2 63:399 343, 1968.
2. Vaughan ED Jr, Sorenson E, Gillenwater JY: Effect of acute and chronic ureteral obstruction on renal hemodynamics and function. Surg. Forum., 19:536 538, 1968.
3. Vaughan ED, Jr: Effect of acute and chronic complete unilateral obstruction on renal hemodynamics and function. Thesis for the Degree of Master of Science in Surgery. University of Virginia, 1969.
4. Vaughan ED Jr, Moore RA, Warren H, Mohler DN, Gillenwater JY: Necrosis of the external genitalia associated with so-dium warfarin therapy of thrombophlebitis. J.A.M.A., 210:2282 2283, 1969.
5. Vaughan ED Jr, Sorenson EJ and Gillenwater JY: The renal hemodynamic response to chronic unilateral complete ureteral occlusion. Invest. Urol. #1, 8:78 90, 1970.
6. Vaughan ED Jr, Sweet RC and Gillenwater JY: Peripheral renin and blood pressure changes following complete unilateral ureteral occlusion. J. Urol., 104:89 92, 1970.
7. Vaughan ED Jr, Alfert HJ and Gillenwater JY: Obstructive uropathy secondary to phimosis and balanoposthitis. Am. J. Dis. Childhood, 120:72 73, 1970.
8. Michaelis L, Vaughan ED Jr, and Potkay S: A method of renin depletion in the dog. Proc. Soc. Exp. Biol. & Med., 135:419 420, 1970.
9. Vaughan ED Jr, Sorenson EJ and Gillenwater JY: Alterations in renal function following release of acute total unilateral oc-clusion. Invest. Urol., 8:450 461, 1971.
10. Vaughan ED Jr, Gillenwater JY and Shenasky JH II: Mechanisms of acute hemodynamic response to ureteral occlusion. Invest. Urol., 9:109 118, 1971.
11. Vaughan ED Jr and Gillenwater JY: Recovery following complete chronic ureteral occlusion: Functional radiographic and pathologic alterations. J. Urol., 106:27 35, 1971.
12. Vaughan ED Jr and Wyker AW Jr: Effect of osmolality on the evaluation of urine for microscopic hematuria. J. Urol., 105:709 711, 1971.
13. Vaughan ED Jr: Broaden you base. The Scalpel, 41:1971.
14. Vaughan ED Jr: Ernst George Ferdinand von Kuster. Invest. Urol., 8:583 584, 1971.
15. Stecker JF, Vaughan ED Jr. and Gillenwater JY: Alterations in renal metabolism occurring in ureteral ob struction in vivo. S.G.O., 133:846848, 1971.
16. Vaughan ED Jr, Grieco ER and Gillenwater JY: Avascular renal cell carcinoma. J. Urol., 107:561 563, 1972.
17. Gillenwater JY, Howards SS and Vaughan ED Jr: Post obstructive diuresis: A rationale for management. Medical World News Review Series Urology 1972:61 62, 1972.
18. Laragh JH, Baer L, Brunner HR, Buhler FR, Sealey JE and Vaughan ED Jr: Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am. J. Med., 52:633 652, 1972.
19. Gillenwater JY, Vaughan ED Jr, Shenasky JH II, Augusta VE, Middleton GW and Panko WB: Experimental hydronephrosis: A summary of research in progress, I. Trans. Amer. Assoc. G.U. Surg., 64:128 135, 1972.
20. Buhler FR, Laragh JH, Baer L, Vaughan ED Jr and Brunner HR: Propranolol inhibition of renin secretion: A specific ap-proach to diagnosis and treatment of renin dependent hypertensive disease. N. Eng. J. Med., 287:1209 1214, 1972.
21. Vaughan ED Jr and Gillenwater JY: Diagnosis, characterization and management of post obstructive diuresis. J. Urol., 109:286 292, 1973.
22. Vaughan ED Jr: Renin's role in renovascular hypertension. Medical World News Review Series, Urology 1973:48 49, 1973.
23. Vaughan ED Jr, Gavras H, Laragh JH and Koss MN: Vascular permeability factor: Dissociation from the angiotensin II in-duced pressor and drinking responses. Nature, 242:334 336, 1973.
24. Vaughan ED Jr, Sweet RE and Gillenwater JY: Unilateral ureteral occlusion: Pattern of nephron repair and compensatory response. J. Urol., 109:979 982, 1973.
25. Gavras H, Brunner HR, Vaughan ED Jr, Laragh JH: Angiotensin sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science 180:1369 1372, 1973.
26. Sealey JE, Buhler FR, Laragh JH and Vaughan ED Jr: The physiology of renin secretion rate and renal plasma flow from peripheral and renal vein renin. Am. J. Med., 55:391 401, 1973.
27. Vaughan ED Jr, Buhler FR, Laragh JH, Sealey JE, Baer L and Bard RH: Renovascular hypertension: Renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow and score for surgical curability. Am. J. Med., 55:402 414, 1973.
28. Buhler FR, Laragh JH, Vaughan ED Jr, Brunner HR, Gavras H and Baer L: The antihypertensive action of propranolol: Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. Am. J. Cardiol., 32:511 522, 1973.
29. Vaughan ED Jr, Laragh JH, Gavras I, Buhler FR, Gavras H, Brunner HR and Baer L: The volume factor in low and normal renin essential hypertension: Its treatment with either spirolactone or chlorthalidone. Am. J. Cardiol., 32:523 532, 1973.
30. Ayers CR, Vaughan ED Jr and Yancey MR: Effect of 1 SAR 8 ALA angiotensin (P 113) on plasma renin and in trarenal pressure in acute dog renovascular hypertension. Circ. Res., 34 35:I 27 I 33, 1974.
31. Vaughan ED Jr, Buhler FR and Laragh JH: Normal renin secretion in hypertensive patients with primarily unilateral chronic hydronephrosis. J. Urol., 112:153 156, 1974.
32. Vaughan ED Jr: Renin sampling: Collection and interpretation. N. Eng. J. Med., 290:1195 1196, 1974.
33. Vaughan ED Jr and Peach MJ: Regulation of aldosterone biosynthesis by "angiotensin III." N. Eng. J. Med., 291:1193, 1974.
34. Keim HJ, Johnson P, Vaughan ED Jr, Beg K and Laragh JH: Quantitative analysis of Tc99mpertechnetate renogram versus RSIVP as screening test in the diagnostic work up of systemic arterial hypertension. Proc. 80th Meeting German Soc. Inter-nat. Med. 1974. Verh. Deut. Gest. Inn. Med., 80:303 306, 1974.
35. Vaughan ED Jr: The role of the renin angiotensin aldosterone system in hypertensive vascular disease. Proc. of the Semi-nars in Dietary Management of Renal Disease and Hypertension. 1:44 50, 1974.
36. Laragh JH, Sealey JE, Buhler FR, Vaughan ED Jr, Brunner HR, Gavras H and Baer L: The renin axis and vasoconstriction volume analysis for understanding and treatment of renovascular and renal hypertension. Am. J. Med., 58:4 13, 1975.
37. Rose JG and Vaughan ED Jr: Common renal pelvis: A case report. J. Urol., 113:234 235, 1975.
38. Gillenwater JY, Westervelt FB, Vaughan ED Jr and Howards SS: Renal function after release of chronic unilateral hy-dronephrosis in man. Kid. Int., 7:179 186, 1975.
39. Gavras H, Brunner HR, Laragh JH, Vaughan ED Jr, Koss M and Cote JJ: Malignant hypertension of DOCA and salt excess: The role of renin and sodium in vascular changes. Circ. Res., 36:300 309, 1975.
40. Vaughan ED Jr and Laragh JH: New concepts of the renin system and of vasoconstriction volume mechanisms; diagnosis and treatment of renovascular and renal hyperten sions. Urol. Clin. of N. Am., 2:237 257, 1975.
41. Vaughan ED Jr and Middleton GW: Genitourinary embryology: A review for the practicing urologist. Urology, 6:139 149, 1975.
42. Moody TE, Vaughan ED Jr and Gillenwater JY: Relationships between renal blood flow and ureteral pressure during 18 hours of total unilateral ureteral occlusion: Implications for changing sites of increased renal resistance. Invest. Urol., 13:246 251, 1975.
43. Sarstedt CA, Vaughan ED Jr and Peach MJ: Selective inhibition by des Asp1 Ile8 angiotensin II of the steroidogenic re-sponse to restricted sodium intake in the rat. Circ. Res., 37:350 358, 1975.
44. Ayers CR, Vaughan ED Jr, Yancey MR, Bing KT, Johnson CC and Morton CL: Negative feedback mechanism controlling renin release. Steroid Hormones 16:249 255, 1975.
45. Vaughan ED Jr, Buhler FR, Laragh JH, Sealey JE, Gavras H and Baer L: Hypertension and unilateral parenchymal renal dis-ease: Evidence for abnormal vasoconstriction volume interaction. J.A.M.A., 233:1177 1183, 1975.
46. Caputy AJ, and Vaughan ED Jr: Physician contact for pre medical students: A pre med extern program. Scalpel, 45:9, 1975.
47. Morris SA, Vaughan ED Jr and Constable WC: Problems in management of bilateral germ cell testicular tumors: Report of three cases and review of literature. J. Urol., 115:566 568, 1976.
48. Peters WA III, and Vaughan ED Jr: Uretheral diverticula in the female: Etiologic factors and post operative results. Obstet. and Gynec., 47:549 552, 1976.
49. Carey RM, Reid RA, Ayers CR, Lynch SS, McLain WL III and Vaughan ED Jr: The Charlottesville blood pressure survey: Value of repeat blood pressure measurement to define the prevalence of labile and sustained hypertension. J.A.M.A., 236:847 851, 1976.
50. Peach MJ, Sarstedt CA and Vaughan ED Jr: Changes in cardiovascular and adrenal cortical responses to angiotensin III in-duced by sodium deprivation in the rat. Circ. Res., 38:117 121, 1976.
51. Larner A, Vaughan ED Jr, Tsai BS and Peach MJ: Role of converting enzyme in the cardiovascular and adrenal cortical re-sponse to (Des Asp1) angiotensin I. Proc. Soc. Exp. Biol. and Med., 152:631 634, 1976.
52. Vaughan ED Jr: Identifying surgically curable renovascular hypertension. Cardiovasc. Med., 1:195 205, 1976.
53. Reid RA, Carey RM, Ayers CR, McLain WL III, Lynch SS and Vaughan ED Jr: The Charlottesville blood pressure survey: Use of door to door survey in hypertensive case finding. Medical Care, 15:324 330, 1977.
54. Ayers CR, Katholi RE, Vaughan ED Jr, Carey RM, Kimbrough HM Jr, Yancey MS and Morton CL: Intrarenal renin angiotensinsodium interdependent mechanism controlling post clamp renal artery pressure and renin release in the con-scious dog with chronic one kidney Goldblatt hypertension. Circ. Res., 40:238 242, 1977.
55. Morris SA, Vaughan ED Jr and Makoui C: Renal plasmacytoma. Urology 9:303 306, 1977.
56. Moody TE, Vaughan ED Jr, Wyker AT and Gillenwater JY: The role of intrarenal angiotensin II in the hemodynamic re-sponse to unilateral ureteral occlusion. Invest. Urol., 14:390 397, 1977.
57. Kimbrough HM Jr, Vaughan ED Jr, Carey RM and Ayers CR: Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ. Res., 40:174 178, 1977.
58. Kimbrough HM Jr and Vaughan ED Jr: Skene's duct cyst in a newborn: Case report and review of the literature. J. Urol., 117:387-388, 1977.
59. Vaughan ED Jr, Crosby IK and Tegtmeyer CJ: Nephroblastoma with right atrial extension pre operative diagnosis and man-agement. J. Urol., 117:530 533, 1977.
60. Katholi RE, Carey RM, Ayers CR, Vaughan ED Jr, Yancey MR and Morton CL: Production of sustained hypertension by chronic intrarenal norepinephrine infusion in conscious dogs. Circ. Res., 40:I 118 I 126, 1977.
61. Vaughan ED Jr, Peach MJ, Ackerly TA, Tsai BS and Larner A: Pressor and sterioidogenic actions of (des Asp1) angiotensin I: Dependency upon conversion of Angiotensin III. Circ. Res., 40:I 94 I 97, 1977.
62. Noller DW, Gillenwater JY, Howards SS and Vaughan ED Jr: Intercostal nerve block with flank incision. J. Urol., 117:759 761, 1977.
63. Bolton WK and Vaughan ED Jr: A comparative study of open surgical and percutaneous renal biopsies. J. Urol., 117:696 698, 1977.
64. Moody TE, Vaughan ED Jr and Gillenwater JY: Comparison of the renal hemodynamic response to unilateral and bilateral ureteral occlusion. Invest. Urol., 14:455 459, 1977.
65. Miller ED Jr, Ackerly JA, Vaughan ED Jr, Peach MJ and Epstein RM: The renin angiotensin system during controlled hyper-tension with sodium nitroprusside. Anesthesiology 47:257 262, 1977.
66. Tegtmeyer CJ, Latour EA, Vaughan ED Jr, Ayers CR, Carey RM and Wellons HA Jr: Clinical experience with saralasin in-fusion in hypertensive patients. Invest. Radiol., 12:496 504, 1977.
67. Viets DH, Vaughan ED Jr and Howards SS: Experience gained from the management of nine cases of bilateral renal cell carcinoma. J. Urol., 118:937 940, 1977.
68. Allen JT, Vaughan ED Jr and Gillenwater JY: The effect of indomethacin on renal blood flow and ureteral pressure in unilat-eral ureteral obstruction in awake dogs. Invest. Urol., 15:324 327, 1978.
69. Carey RM, Vaughan ED Jr, Ackerly JA, Peach MJ and Ayers CR: The immediate pressor effect of saralasin in man. J. Clin. Endo. and Metab., 46:36 43, 1978.
70. Vaughan ED Jr, Carey RM, Peach MJ, Ackerly JA and Ayers CR: The renin response to diuretic therapy: A limitation of antihypertensive potential. Circ. Res., 42:376 381, 1978.
71. Carey RM, Peach MJ, Vaughan ED Jr and Ayers CR: Activity of (des Aspartyl1) angiotensin II and angiotensin II in man: Differences in blood pressure and adrenocortical responses during normal and low sodium intake. J. Clin. Invest., 61:20 31, 1978.
72. Harrison RB and Vaughan ED Jr: Diffuse cortical calcification in rejected renal transplants. Radiology 126:635 636, 1978.
73. Carey RM, Peach MJ, Vaughan ED Jr and Ayers CR: Responses to angiotensin II and (des Aspartyl1) angiotensin II in man: Are there different receptors? Circ. Res., 43:I 63 I 69, 1978.
74. Thiagarajah S, Vaughan ED Jr and Kitchen JD: Retrograde ejaculation: Successful pregnancy following combined sympath-omimetric medical and insemination. Fertil. Steril., 30:96 97, 1978.
75. Weed WC, Vaughan ED Jr, Glenn AW and Peach MJ: Increased aldosterone excretion in the saralasin resistant phase of two kidney Goldblatt hypertension. Surg. Forum, 29:636 638, 1978.
76. Vaughan ED Jr: Recognition and management of post obstructive diuresis. Weekly Urology Update Series, 1:#18, 1978.
77. Moody TE and Vaughan ED Jr: Steroids in the treatment of retroperitoneal fibrosis. J. Urol., 121:109 111, 1979.
78. Datta NC, Henson GF, Vaughan ED Jr and Nolan SP: Leaking left hypogastric artery aneurysm causing bilateral ureteric obstruction. Urology 13:146 149, 1979.
79. Keim HJ, Johnson PM, Vaughan ED Jr, Beg K, Follett DA, Freeman LM and Laragh JH: Computer assisted static/dynamic renal imaging: A screening test for renovascular hypertension. J. of Nuclear Med., 20:11 17, 1979.
80. Vaughan ED Jr, Carey RM, Ayers CR, Peach MJ, Tegtmeyer CJ and Wellons HA Jr: A physiologic definition of blood pressure response to renal revascularization in patients with renovascular hypertension. Kid. Int., 15:S 83 S 92, 1979.
81. Vaughan ED Jr and Peach MJ: (Editorial) (Sar1 Ala8) angiotensin II: Saralasin. Kid. Int., 15:S 1 S 3, 1979.
82. Weed WC, Vaughan ED Jr and Peach MJ: Prolongation of the saralasin response state of the kidney one clip Goldblatt hy-pertension in the rat by the orally administered converting enzyme inhibitor captopril. Hypertension 1:8 12, 1979.
83. Vaughan ED Jr, Carey RM, Ayers CR and Peach MJ: Hemodialysis resistant hypertension: Control with an orally active inhibitor of angiotensin converting enzyme. J. Clin. Endo. and Metab., 48:869 871, 1979.
84. Vaughan ED Jr.: Laboratory tests in the evaluation of renal hypertension. Urol. Clin. of N. Am., 6:485 502, 1979.
85. McCarron JP and Vaughan ED Jr: Clinical evaluation of urinary tract obstruction. Genitourinary Med., 1:37 48, 1979.
86. Carey RM, Ayers CR and Vaughan ED Jr: Activity of (desAspartyl) angiotensin II in primary aldosteronism. J. Clin. Invest., 63:718 726, 1979.
87. Herf SM, Teates DC, Tegtmeyer CJ, Vaughan ED Jr, Ayers CR and Carey RM: Identification and differentiation of surgi-cally correctable hypertension due to primary aldosteronism. Am. J. Med., 67:397 402, 1979.
88. Leslie BR, Case DB, Sullivan JF, and Vaughan ED Jr: Absence of bloodpressure lowering effect on captopril in anephric patients. Br. Med. J., 1:1067 1068, 1980.
89. Velcek D, Sniderman KW, Vaughan ED Jr, Sos TA and Muecke EC: Penile flow index utilizing a Doppler pulse wave analy-sis to identify penile vascular insufficiency. J. Urol., 123:699 673, 1980.
90. Williams HE and Vaughan ED Jr: Renal stone disease. Update Your Medicine, Cornell University Medical Center.
91. Krieger JN, Stubenbord WT and Vaughan ED Jr: Transplantation in children with end stage renal disease of urologic origin. J. Urol., 124:508 512, 1980.
92. Pitts WR, Kazam E, Gray GF Jr and Vaughan ED Jr: Ultrasonography, computerized transaxial tomography and pathology of angiomyolipoma of the kidney: Solution to a diagnostic dilemma. J. Urol., 124:907 909, 1980.
93. Ackerly JA, Peach MJ, Vaughan ED Jr and Glenn AW: Formation of (des Asp1)angiotensin I by the perfused rat lung. En-docrinology 107:1699 1704, 1980.
94. Johns DW, Baker KM, Ayers CR, Vaughan ED Jr, Carey RM, Peach MJ, Yancey MS, Ortt EM and Williams SC: Acute and chronic effect of captopril in hypertensive patients. Hypertension 2:567 575, 1980.
95. Baker KM, Johns DW, Vaughan ED Jr, Ayers CR and Carey RM: Antihypertensive effects of angiotensin blockade: Saral-asin versus captopril. Clin. and Exp. Hyperten., 2(6):947 954, 1980.
96. Levens NR, Peach MJ, Vaughan ED Jr, Weed WC and Carey RM: Response of blood pressure and angiotensin converting enzyme activity to acute captopril administration in normotensive and hypertensive rats. Endocrinology 108:536 544, 1981.
97. Levens NR, Peach MJ, Vaughan ED Jr and Carey RM: Demonstration of a primary antidiuretic action of angiotensin II: Ef-fects of intrarenal converting enzyme inhibition in the conscious dog. Endocrinology 108:318 330, 1981.
98. Greenberg RE, Vaughan ED Jr and Pitts WR: Normal pregnancy and delivery following ileal conduit urinary diversion. J. Urol., 125:172-173, 1981.
99. Riehle RA, Vaughan ED Jr, Kazam E, Sniderman KW and Gray GF Jr: Obstructive uropathy with infection Azotemia and flank mass. Clinicopathologic Conference. J. Urol., 125:235 240, 1981.
100. Mills C, McGovern J, Mininberg DT, Coleman J, Muecke EC and Vaughan ED Jr: An analysis of different techniques for distal hypospadias repair: The price of perfection. J. Urol., 125:701 702, 1981.
101. Morrison AR, Thornton F, Blumberg A and Vaughan ED Jr: Thromboxane A2 is the major arachidonic acid metabolite of human cortical hydronephrotic tissue. Prostaglandin 21:171 181, 1981.
102. Greenberg RE and Vaughan ED Jr: Obstructive uropathy: Recognition and management. Continuing Education for the Fam-ily Physician. 1:43 52, 1981.
103. Vaughan ED Jr, Case DB, Pickering TG, Sos TA, Sniderman KW, Sealey JE and Laragh JH: Diagnosis and management of renovascular hypertension. Cardiovascular Review and Reports. 2:881 888, 1981.
104. Vaughan ED Jr: Success in management of renovascular hypertension: Why so? Am. J. of Neph., 1:133 137, 1981.
105. Peterson RE, Kourides IA, Horwith M, Vaughan ED Jr, Saxena BB and Fraser RAR: Luteinizing hormone and sub-unit secreting pituitary tumor: Positive feedback of estrogen. J. of Clin. Endo. and Metab., 52:692 698, 1981.
106. Vaughan ED Jr, Case DB, Pickering TG, Sos TA, Sealey JE and Laragh JH: Dijagnoza 1 Lecenje Renovaskularne Hiperten-zije. Uroloski Arhiv Archivum Urologieum 15:37 49, 1981.
107. Riehle RA Jr, Vaughan ED Jr: Renin participation in hypertension associated with unilateral hydronephrosis. J Urol., 126:243-246, 1981.
108. Israel AR, Susin M and Vaughan ED Jr: Microhematuria associated with gold therapy: Evaluation and management. J. Urol., 127:477-478, 1982.
109. Parnell JP, Marshall VF and Vaughan ED Jr: Primary mangement of urinary stress incontinence by the Marshall Marchetti Krantz vesicourethropexy. J. Urol., 127:679 682, 1982.
110. Sos TA, Vaughan ED Jr, Pickering TG, Case DB, Sniderman KW, Sealey JE and Laragh JH: Diagnosis of renovascular hy-pertension and evaluation of "Surgical" curability. Urol. Radiol., 3:199 204, 1982.
111. Sos TA, Saddekni S, Sniderman KW, Weiner M, Beinart C, Pickering TG, Case DB, Vaughan ED Jr and Laragh JH: Renal artery angioplasty: Techniques and early results. Urol. Radiol., 3:223 232, 1982.
112. Beinart C, Sniderman KW, Saddekni S, Weiner M, Vaughan ED Jr and Sos TA: Left renal vein hypertension: A cause of occult hematuria. Radiology 145:647 650, 1982.
113. Beinart C, Sniderman KW, Tamura S, Vaughan ED Jr and Sos TA: Left renal vein inferior vena cava pressure relationships in humans. J. Urol., 127:1070 1071, 1982.
114. Vaughan ED Jr: Current advances in the diagnosis and treatment of renovascular hypertension. The Kidney 15:23 27, 1982.
115. Mills C and Vaughan ED Jr: Carcinoma of the ureter: Natural history, management and five year survival. J. Urol., 129:275 277, 1983.
116. Morgeau JG, Wilson DR, Vaughan ED Jr and Yarger W: Symposium: Obstructive Uropathy. Annals Royal College Physi-cians and Surgeons of Canada. 15:639 640, 1983.
117. Vaughan ED Jr: Why Seminars? Seminars in Urology, 1:1, 1983.
118. McCarron JP, Mills C and Vaughan ED Jr: Tumors of the renal pelvic and ureter: Current concepts and management. Semi-nars in Urology 1:75 81, 1983.
119. Sosa RE and Vaughan ED Jr: Evaluation for surgically curable hypertension. A.U.A. Update Series. Lesson 31, 1983.
120. Vaughan ED Jr, Marion DN, Sealey JE, Camargo MJF, Kleinert HD, Maack T and Laragh JH: Atrial natriuretic extract ef-fect on renal hemodynamics in the rabbit. Surg. Forum., 34:690 692, 1983.
121. Sos TA, Pickering TG, Phil D, Sniderman K, Saddekni S, Case DB, Silane MF, Vaughan ED Jr and Laragh JH: Percutane-ous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N. Eng. J. Med., 309:274 279, 1983.
122. Vaughan ED Jr: Editorial review: To improve, not impair. J. Urol., 130:1155, 1983.
123. Nicholson JP Jr, Vaughan ED Jr, Pickering TG, Resnick LM, Artusio J, Kleinert HD, Lopez Overjero JA and Laragh JH: Pheochromocytoma and prazosin. Annals of Int. Med., 99:477 479, 1983.
124. Kleinert HD, Leslie BR, Laragh JH, Vaughan ED Jr and Sealey JE: Comparable effect of isotonic infusion on blood pressure in the anephric rat. Hypertension 5:421 426, 1983.
125. Riehle RA Jr and Vaughan ED Jr: Genitourinary disease in the elderly. Med. Clin. of N. Am., 67:445 461, 1983.
126. Schlossberg SM and Vaughan ED Jr.: The mechanism of unilateral postobstructive diuresis. J. Urol., 131:534 536, 1984.
127. Schlossberg SM, Finkel ML, Vaughan ED Jr, Riehle RA Jr and McCarthy EG: Second opinion for urological surgery. J. Urol., 131:209 212, 1984.
128. Vaughan ED Jr: What's new in urology? Bull. Am. College of Surgeons. January, 1984.
129. Sosa RE, Muecke EC, Vaughan ED Jr and McCarron JP Jr: Renal cell carcinoma extending into the inferior vena cava: The prognostic significance of the level of caval involvement. J. Urol., 132:1097 1100, 1984.
130. Vaughan ED Jr, Case DB, Pickering TG, Sosa RE, Sos TA and Laragh JH: Clinical evaluation for renovascular hypertension and therapeutic decisions. Urol. Clin. of N. Am., 11:393 407, 1984.
131. Pickering TG, Sos TA, Vaughan ED Jr, Case DB, Sealey JE, Harshfield GA and Laragh JH: Predictive value and changes of renin secretion in hypertensive patients with unilateral renovascular disease undergoing successful angioplasty. Am. J. of Med., 76:398 404, 1984.
132. Maack T, Marion DN, Camargo MF, Kleinert HD, Laragh JH, Vaughan ED Jr and Atlas, S.A.: Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin aldosterone system in dogs. Am. J. of Med., 77:1069 1075, 1984.
133. Parnell JP II, Marshall VF and Vaughan ED Jr: Management of recurrent urinary stress incontinence by the Mar-shall Marchetti Krantz vesicourethropexy. J. Urol., 132:912 914, 1984.
134. Sos TA, Pickering TG, Sniderman KW, Saddekni S, Case DB, Silane MF, Vaughan ED Jr and Laragh JH: Percutaneous transluminal renal angioplasty in renovascular hypertension. Letter to the Editor Response. N. Eng. J. Med., Feb. 2, pp. 322 323, 1984.
135. Loo MH, Marion DN, Vaughan ED Jr, Felsen D, Albanese C and Spellman M Jr: Effect of chronic unilateral ureteral ob-struction on renal function in rabbits: Possible role of thromboxane. Surg. Forum., 35:642 644, 1984.
136. Bander NH, Welt S, Houghton AN, Lloyd KO, Grando R, Yeh S, Whitmore WF Jr, Vaughan ED Jr and Old LJ: Radionu-clide imaging of human renal cancer with labeled monoclonal antibodies. Surg. Forum., 35:652 654, 1984.
137. Volpe M, Odell G, Kleinert HD, Camargo MJ, Laragh JH, Lewicki JA, Maack T, Vaughan ED Jr and Atlas SA: Antihypertensive and aldosterone lowering effects of synthetic atrial natriuretic factor in renin dependent renovascular hypertension. J. of Hypertension. 2:313 315, 1984.
138. Vaughan ED Jr, Case DB, Pickering TG, Sosa RE, Sos TA and Laragh JH: Indication for interven tion in patients with reno-vascular hypertension. Am. J. of Kid. Dis., 5:A136 A143, 1985.
139. Loo MH and Vaughan ED Jr: Obstructive nephropathy and postobstructive diuresis. Urology Update Series. IV Lesson 9, 1985.
140. Wong PY K, Pieroni JP, Chao PH W, Sarrubbi D, Marion DN, Albanese CT and Vaughan ED Jr: Deficiency in 15 hydroxyprostaglandin dehydrogenase activity following unilateral ureteral obstruction of the dog kidney. J. Pharm. Exp. Therap., 232(2):470 474, 1985.
141. Bander NH, Cordon Cardo C, Finstad CL, Whitmore WF Jr, Vaughan ED Jr, Oettgen HF, Melamed M and Old LJ: Immu-nohistologic dissection of the human kidney using monoclonal antibodies. J. Urol., 133:502 505, 1985.
142. Volpe M, Odell G, Kleinert HD, Camargo MJ, Laragh JH, Maack T, Vaughan ED Jr and Atlas SA: Effects of atrial natri-uretic factor on blood pressure, renin aldosterone in renovascular hypertensive rats. Hypertension 7:I 43 I 48, 1985.
143. Imperato McGinley J, Binienda Z, Arthur A, Mininberg DT, Vaughan ED Jr and Quinby F: The development of a male pseudohermaphrodite rat using an inhibitor of the enzyme 5 alpha-reductase. Endocrinology 116:807 812, 1985.
144. Vaughan ED Jr: Renovascular hypertension. Kid. Int., 27:811 827, 1985.
145. Miller IJ, Suthanthiran M, Riggio RR, Williams JJ, Riehle RA Jr, Vaughan ED Jr, Stubenbord WT, Cheigh JS and Stenzel KH: The impact of renal donation: Long term (clinical and biochemical) follow up of living donors in a single center. Am. J. of Med., 79:201, 1985.
146. Sosa RE, Volpe M, Marion DN, Atlas SA, Laragh JH, Vaughan ED Jr and Maack T: Renal hemodynamic effects of atrial natriuretic factor. Surg. Forum., 36:633 635, 1985.
147. Felsen D and Vaughan ED Jr: Urologic Pharmacology Part I. Seminars in Urology, Vol. III, No. 3 (August), 1985.
148. Weisman SM, Felsen D and Vaughan ED Jr: Indications and contraindications for the use of nonsteroidal antiinflammatory drugs in urology. Seminars in Urology, Vol. III, No. 4 (November), pp. 301 310, 1985.
149. Sosa RE and Vaughan ED Jr: Pharmacologic probes to identify patients with renovascular hypertension. Seminars in Urol-ogy, Vol. III, No. 4 (November), pp. 317 324, 1985.
150. Weisman SM, Felsen D and Vaughan ED Jr: Platelet activating factor is a potent stimulus for renal prostaglandin synthesis: Possible significance in unilateral ureteral obstruction. J. Pharm. and Exp. Therap., 235:10 15, 1985.
151. Sosa RE, Huffman JL, Riehle RA Jr and Vaughan ED Jr: Upper urinary tract stone extraction utilizing the ureteropyeloscope. In Endourology Proceedings of the Third Congress of the International Society of Urologic Endoscopy. Matouschek, E. (Ed.) Karlsruhe, BuA Verlag Werner Steinbruk, pp. 405 406, 1985.
152. Vaughan ED Jr: Ureteropyeloscope Fracture. Urologists' Correspondence Club, August 21, pp. 101 102, 1985.
153.&nbs瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀匀漀猀愀 刀䔀Ⰰ 嘀漀氀瀀攀 䴀Ⰰ 䴀愀爀椀漀渀 䐀一Ⰰ 䜀氀漀爀椀漀猀漀 一Ⰰ 䰀愀爀愀最栀 䨀䠀Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀Ⰰ 䴀愀愀挀欀 吀 愀渀搀 䄀琀氀愀猀 匀䄀㨀 䔀昀 昀攀挀琀 漀昀 愀琀爀椀愀氀 渀愀琀爀椀甀爀攀琀椀挀 昀愀挀琀漀爀 漀渀 爀攀渀椀渀 猀攀挀爀攀琀椀漀渀Ⰰ 瀀氀愀猀 洀愀 爀攀渀椀渀 愀渀搀 愀氀搀漀猀琀攀爀漀渀攀 椀渀 搀漀最猀 眀椀琀栀 愀挀甀琀攀 甀渀椀氀愀琀攀爀愀氀 爀攀渀愀氀 愀爀琀攀爀礀 挀漀渀猀琀爀椀挀琀椀漀渀⸀ 䨀⸀ 漀昀 䠀礀瀀攀爀琀攀渀ⴀ猀椀漀渀⸀Ⰰ ㌀㨀⠀匀甀瀀瀀氀 ㌀⤀㨀匀㈀㤀㤀 匀㌀ ㈀Ⰰ 㤀㠀㔀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㔀㐀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀吀椀昀昀愀渀礀 倀Ⰰ 䴀漀爀猀攀 䴀Ⰰ 䈀漀猀氀 䜀Ⰰ 圀栀椀琀洀漀爀攀 圀䘀 䨀爀Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀 愀渀搀 䠀攀爀爀 䠀㨀 匀攀焀甀攀渀琀椀愀氀 攀砀挀椀猀椀漀渀 漀昀 爀攀猀椀搀甀愀氀 琀栀漀爀愀挀椀挀 愀渀搀 爀攀琀ⴀ爀漀瀀攀爀椀琀漀渀攀愀氀 洀愀猀猀攀猀 愀昀琀攀爀 挀栀攀洀漀琀栀攀爀愀瀀礀 昀漀爀 猀琀愀最攀 䤀䤀䤀 最攀爀洀 挀攀氀氀 琀甀洀漀爀猀⸀ 䌀愀渀挀攀爀 㔀㜀㨀㤀㜀㠀 㤀㠀㌀Ⰰ 㤀㠀㘀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㔀㔀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀刀椀攀栀氀攀 刀䄀 䨀爀Ⰰ 一愀猀氀甀渀搀 䔀Ⰰ 䘀愀椀爀 圀刀 愀渀搀 嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䤀洀瀀愀挀琀 漀昀 猀栀漀挀欀 眀愀瘀攀 氀椀琀栀漀琀爀椀瀀猀礀 漀渀 琀栀攀 洀愀渀愀最攀洀攀渀琀 漀昀 甀瀀瀀攀爀 甀爀椀ⴀ渀愀爀礀 琀爀愀挀琀 挀愀氀挀甀氀椀⸀ 唀爀漀氀漀最礀 ㈀㠀⠀㐀⤀㨀㈀㘀 ㈀㘀㤀Ⰰ 㤀㠀㘀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㔀㘀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀䰀漀漀 䴀䠀Ⰰ 䴀愀爀椀漀渀 䐀一Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀Ⰰ 䘀攀氀猀攀渀 䐀 愀渀搀 䄀氀戀愀渀攀猀攀 䌀吀㨀 䔀昀昀攀挀琀 漀昀 琀栀爀漀洀戀漀砀愀渀攀 椀渀栀椀戀椀琀椀漀渀 漀渀 爀攀渀愀氀 戀氀漀漀搀 昀氀漀眀 椀渀 搀漀最猀 眀椀琀栀 挀漀洀瀀氀攀琀攀 甀渀椀氀愀琀攀爀愀氀 甀爀攀琀攀爀愀氀 漀戀猀琀爀甀挀琀椀漀渀⸀ 䨀⸀ 漀昀 唀爀漀氀漀最礀⸀ ㌀㘀㨀㌀㐀㌀ ㌀㐀㜀Ⰰ 㤀㠀㘀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㔀㜀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀刀椀攀栀氀攀 刀䄀 䨀爀Ⰰ 䘀愀椀爀 圀 愀渀搀 嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䔀砀琀爀愀挀漀爀瀀漀爀攀愀氀 猀栀漀挀欀 眀愀瘀攀 氀椀琀栀漀琀爀椀瀀猀礀 昀漀爀 甀瀀瀀攀爀 甀爀椀渀愀爀礀 琀爀愀挀琀 挀愀氀挀甀氀椀㨀 伀渀攀 礀攀愀爀 攀砀瀀攀爀椀攀渀挀攀 愀琀 愀 猀椀渀最氀攀 挀攀渀琀攀爀⸀ 䨀⸀䄀⸀䴀⸀䄀⸀Ⰰ ㈀㔀㔀⠀㔀⤀㨀㈀ 㐀㌀ ㈀ 㐀㠀Ⰰ 㤀㠀㘀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㔀. Sosa RE and Vaughan ED Jr: Renovascular Hypertension: Home Study. Home Study Course 1986.
159. Reckler J, Rodman JS, Jacobs D, Rotterdam H, Marion D and Vaughan ED Jr: Urothelial injury to the rabbit bladder from various alkaline and acidic solutions used to dissolve kidney stones. J. of Urol., 136(1):181 183, 1986.
160. Carter HB, Riehle RA Jr, Koizumi JH, Amberson J and Vaughan ED Jr: Fine needle aspiration of the abnormal prostate: A cytohistologic correlation. J. of Urol., 135:294 298, 1986.
161. Tiffany P, Vaughan ED Jr, Marion D and Amberson J: Hypergastrinemia following antral gastocystoplasty. J. of Urol., 136:692 695, 1986.
162. Weisman SM, Felsen D and Vaughan ED Jr: The effect of sodium intake on renal prostaglandin production. Proc. Soc. Exp. Biol. & Med., 181:357-363, 1986.
163. Saltzman B, Pitts WR and Vaughan ED Jr: Extragonadal retroperitoneal germ cell tumors without apparent testicular in-volvement: A search for the source. Urology 27:504 507, 1986.
164. Imperato McGinley J, Binienda Z, Gedney J and Vaughan ED Jr: Nipple differentiation in fetal male rats treated with an inhibitor of the enzyme 5 alpha reductase: Definition of a selective role for dihydrotestosterone. Endocrinology 118:132 137, 1986.
165. Loo MH, Marion D, Vaughan ED Jr, Moody TE, Felsen D and Weisman SM: Thromboxane A2 blockade fails to reverse the increased renovascular resistance following unilateral ureteral occlusion. Surg. Forum, 37:650 652, 1986.
166. Pickering TG, Sos TA, Vaughan ED Jr and Laragh JH: Differing patterns of renal vein renin secretion in patients with reno-vascular hypertension, and their role in predicting the response to angioplasty. Nephron 44 (Suppl. 1):8 11, 1986.
167. Sosa RE, Volpe M, Marion DN, Atlas SA, Laragh JH, Vaughan ED Jr and Maack T: Relationship between renal hemody-namic and natriuretic effects of atrial natriuretic factor. Am. Physiol. Soc., F520 F524, 1986.
168. Sternberg CN, Yagoda A, Bander NH, Whitmore WF Jr, Melamed M, Fleisher M, Huffman JL, Fannucci M, Hollander P and Vaughan ED Jr: Phase I/II trial of intravesical methotrexate for superficial bladder tumors. Cancer Chemother. Pharmacol., 18:265 269, 1986.
169. Saltzman B and Vaughan ED Jr: Staghorn calculi: Is intervention always indicated? A.U.A. Update Series, Lesson 8, Vol. VI., 1987.
170. Somers WJ and Vaughan ED Jr: New strategies in the management of benign prostatic disease. New Developments in Medi-cine, Vol. 1:33 44, 1987.
171. Loo MH, Egan D, Vaughan ED Jr, et al.: The effect of the thromboxane A2 synthesis inhibitor OKY 046 on renal function in rabbits following release of unilateral ureteral obstruction. J. of Urol., 137:571 576, 1987.
172. Kurz KR, Pitts WR and Vaughan ED Jr: The natural history of patients less than forty years old with bladder tumors. J. of Urol., 137:395 397, 1987.
173. Imperato McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS and Vaughan ED Jr: Reversibility of a catecholamine induced dilated cardiomyopathy in a patient with pheochromocytoma. N. Eng. J. of Med., 316:761 763, 1987.
174. Amberson JB, Vaughan ED Jr, Gray GF and Naus GJ: Flow cytometric analysis of nuclear DNA from adreno cortical tu-mors: A retrospective study using paraffin embedded tissue. Cancer 59:2091-2095, 1987.
175. Amberson JB, Vaughan ED Jr, Gray GF and Naus GJ: Flow cytometric determination of nuclear DNA content in benign ad-renal pheochromocytoma. Urology 30:102 104, 1987.
176. Vaughan ED Jr: The Ureter; Editorial Overview. Seminars in Urology, Vol. V, No. 3:147, 1987.
177. Sosa RE, Riehle RA and Vaughan ED Jr: The management of ureteral calculi. Seminars in Urology, Vol. V, No. 3:212 216, 1987.
178. Felsen D, Loo MH and Vaughan ED Jr: Effect of ureteral obstruction on renal hemodynamics. Seminars in Urology, Vol. V, No. 3:160 166, 1987.
179. Sosa RE, Vaughan ED Jr and Gibbons RP: Retroperitoneal Fibrosis. A.U.A. Update Series, Lesson 21, Volume VI, 1987.
180. Riehle RA Jr, Carter HB and Vaughan ED Jr: Quantitative and crystallographic analysis of stone fragments voided after ex-tracorporeal shock wave lithotripsy. J. of Endourology, 1(1):37 44, 1987.
181. Saltzman B and Vaughan ED Jr: Staghorn calculi: Is intervention always indicated? A.U.A. Update Series, Lesson 8, Vol-ume VI, 1987.
182. Mellinger BC, Vaughan ED Jr, Thompson SL, and Goldstein M: Correlation between intracavernous papaverine injection and doppler analysis in impotent men. Urology, 30:416 419, 1987.
184. Carter HB, Amberson JB, Bander NH, Badalament R, Gorelick J, Vaughan ED Jr and Whitmore WF Jr: Newer diagnostic techniques for bladder cancer. Urol. Clin. of N. Am., 14(4):763 769, 1987.
185. McGovern JH, Vaughan ED Jr and Coleman JW: Urinary diversion in cancer of the prostate. Prostate Cancer, Part B: Imag-ing Techniques, Radiotherapy, Chemotherapy, and Management Issues, pp. 467 471, 1987.
186. Riehle RA Jr, Carter HB and Vaughan ED Jr: Quantitative and crystallographic analysis of stone fragments voided after ex-tracorporeal shock wave lithotripsy. J. of Endourol., 1(1):37 44, 1987.
187. Weisman SM, Freund RM, Felsen D and Vaughan ED Jr: Kadsurenone differentially affects platelet activating factor (PAF) and peptide stimulated prostaglandin (PG) release in unilateral ureteral obstruction (UUO). In New Horizons in Platelet Acti-vating Factor Research. Winslow, C.M. & Lee, M.L. (eds)., John Wiley, Chichester, pp. 329 334, 1987.
188. Chernesky CE, Rodman JS, Reckler J, Rotterdam H, Marion D, Boolbol J and Vaughan ED Jr: Urothelial injury to the rabbit bladder from alkaline irrigants useful in the treatment of uric acid stones. J. Urol., 138:983 984, 1987.
189. Vaughan ED Jr and Phillips H: Modified posterior approach for right adrenalectomy. Surg Gynecol Obstet., 165:453-455, 1987.
190. Kurz KR, Pitts WR, Speer D and Vaughan ED Jr: Palliation of ano rectal carcinoma using the urologic resectoscope. Surg. Gynec. & Obstet., 166:60 62, 1988.
191. Vaughan ED Jr: Innovation and Excellence. Ramon Guiteras Lecture. American Urological Association., 139:6 8, 1988.
192. Gorelick JI, Senterfit LB and Vaughan ED Jr: Quantitative bacterial tissue cultures from 209 prostatectomy sepcimens: Findings and Implications. J. Urol., 139:57 60, 1988.
193. Gilbert BR, Russo P, Zirinsky K, Kazam E, Fair W and Vaughan ED Jr: Intraoperative sonography: Application in renal cell carcinoma. J. Urol., 139:582 584, 1988.
194. Gilbert BR, Riehle RA, and Vaughan ED Jr: Extracorporeal shock wave lithotripsy and its effect on renal function. J. Urol., 139:482 485, 1988.
195. Loo MH, Felsen D, Weisman S, Marion D and Vaughan ED Jr: Pathophysiology of obstructive nephropathy. World J. Urol., 6:53 60, 1988.
196. Aronne LJ, Braham RL, Riehle RA Jr, Vaughan ED Jr and Ruchlin HS: Cost effectiveness of extracorporeal shock wave lithotripsy. Urology, 31:225 230, 1988.
197. Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED Jr, Bander N, Weiselberg LR, Geller N, Hollander PS, Lipperman R, Fair WR and Whitmore WF: M Vac (methotrexate, vinblastine, adriamycin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J. Urol., 139:461 469, 1988.
198. Scher H, Yagoda A, Herr H, Sternberg C, Bosl G, Morse M, Sogani P, Watson R, Dershaw DD, Reuter V, Geller N, Hol-lander P, Vaughan ED Jr, Whitmore W and Fair W: Neoadjuvant M Vac (methotrexate, vinblastine, adriamycin and cis-platin): Effect on the primary bladder lesion. J. Urol., 139:470 474, 1988.
199. Weisman SM, Freund RM, Felsen D and Vaughan ED Jr: Differential effect of platelet activating factor (PAF) receptor an-tagonists on peptide and PAF stimulated prostaglandin release in unilateral ureteral obstruction. Biochem. Pharmac., 37:2927 2932, 1988.
200. Coleman J, McGovern J, Vaughan ED Jr and Chung Ping MA: Urinary diversion in cancer of the prostate. Southeast Asia J. of Surg., 10(1):68, 1988.
201. Hinman F Jr, Boyce WH, Kerstein MD, Vaughan ED Jr and Peters PC: Financing residency training in urology. J. Urol., 139:458 460, 1988.
202. Gilbert BR and Vaughan ED Jr: A Urologist's view of renal pathophysiology, Part I and II. A.U.A. Update Series, Lesson 25, Vol. VII., 1988.
203. Rink RC, Leong CH and Vaughan ED Jr: The use of gastrocystoplasty. Dialogues in Ped. Urol., 11(9), September, 1988.
204. Hesse DG, Silen ML, Felsen D, Moldawer LL, Davatelis GN, Cerami A, Lowry SF and Vaughan ED Jr: Local renal cachec-tin/tumor necrosis factor production is associated with acute renal pathology in chronic endotoxemia. Surgical Forum, 39:680 682, 1988.
205. Vaughan ED Jr and Sosa RE: Complications of ureteroscopy. A.U.A. Update Series, Lesson 35, Vol. VII., 1988.
206. Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani P, Vaughan ED Jr, Bander N, Geller N, Fair WR, Whitmore WF: Chemotherapeutic management of invasive bladder carcinoma. Eur. Uro. (suppl. 1), 14:19 20, 1988.
207. Vaughan ED, Jr., Sosa RE: Editorial. World J. Urol., 7:57 58, 1989.
208. Sosa RE, Vaughan ED, Jr.: Hypertension of renal origin. World J. Urol., 7:64 71, 1989.
209. Vaughan ED, Jr.: Diagnosis of adrenal disorders in hypertension. World J. Urol., 7:111 116, 1989.
210. Somers WJ, Felsen D, Chou T C, Marion DN, Chernesky CE, Vaughan ED, Jr.: An In Vivo evaluation of alpha adrenergic receptors in canine prostate. J. of Urol., 141:1230 1232, 1989.
211. Kane MH, Rodman JS, Horten B, Reckler J, Marion DN, Vaughan ED, Jr.: Urothelial injury from EDTA used as an irrigant in the urinary tract. J. of Urol., 142:1359 1360, 1989.
212. Bander NH, Finstad CL, Cordon Cardo C, Ramsawak RD, Vaughan ED Jr, Whitmore WF Jr, Oettgen HF, Melamed MR, and Old LJ: Analysis of mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. Cancer Res., 49:6774 6780, 1989.
213. Sosa RE, Vaughan ED Jr: Renovascular hypertension: Background, pathophysiology, pathology and clinical evaluation. A.U.A. Update Series, Lesson 18, Vol. VIII, 1989.
214. Vaughan ED Jr, Sosa RE: Renovascular hypertension: Treatment options. A.U.A. Update Series, Lesson 36, Vol. VIII, 1989.
215. Beck EM, Vaughan ED Jr, Sosa RE: The pulsed dye laser in the treatment of ureteral calculi. Seminars in Urol., 7(1):25 29, 1989.
216. Scher HE, Herr HW, Sternberg CN, Bosl G, Morse MJ, Sogani P, Watson RC, Dershaw DD, Reuter V, Curley T, Vaughan ED Jr, Whitmore WF, Fair W, Yagoda A: Neo adjuvant chemotherapy for invasive bladder cancer: Experience with the M VAC regimen. Brit. J. Urol., 64:250 256, 1989.
217. Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED Jr, Bander N, Weiselberg L, Rosado K, Smart T, Lin S Y, Penenberg D, Fair WR and Whitmore WF Jr: M VAC for advanced transitional cell carcinoma of the urothelium: Efficacy, and patterns of response and relapse. Cancer, 64:2448 2458, 1989.
218. Crowley AR, Byrne JC, Vaughan ED Jr, Marion DN: The effect of acute obstruction on ureteral function. J. Urol., 143:596 599, 1990.
219. Felsen D, and Vaughan ED Jr: This month in investigative urology: Platelet activating factor: A mediator of renal pathol-ogy? J Urol., 144:140, 1990.
220. Felsen D, Loo MH, Marion DN, Vaughan ED Jr: Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction. J Urol., 144:141 145, 1990.
221. Freedman AM, Gayle LB, Vaughan ED Jr, Hoffman LA: One stage repair of the anterior abdominal wall using bilateral rec-tus femoris myocutaneous flaps. Ann Plast Surg., 25:299 302, 1990.
222. Gilbert BR, Vaughan ED Jr: Pathophysiology of the aging kidney. Clin in Geriat Med., 6(1):13 30, 1990.
223. Kane M, Fields D, Vaughan ED Jr: Medical management of benign prostatic hyperplasia. Advances in Urology, 3:1 22, 1990.
224. Kane M, Fields D, Vaughan ED Jr: Medical management of benign prostatic hyperplasia. Urology (Supplement), 36(5):5 12, 1990.
225. Mellinger BC, Fried JJ, Vaughan ED Jr: Papaverine induced penile blood flow acceleration in impotent men measured by duplex scanning. J Urol., 144:897 899, 1990.
226. Mellinger BC, and Vaughan ED Jr: Penile blood flow changes in the flaccid and erect state in potent young men measured by duplex scanning. J Urol., 144:894 896, 1990.
227. Steckler RE, Riehle RA Jr, Vaughan ED Jr: Hyperfiltration induced renal injury in normal man: Myth or reality. J Urol., 144:1323 1327, 1990.
228. Vaughan ED Jr: Newer options in managing prostate disease. Geriatrics, Vol. 45, No. 11, 1990.
229. Cerfolio RJ, Morgan AS, Hirvela ER, Vaughan ED Jr: Idiopathic retroperitoneal fibrosis: Is there a role for postoperative steroids? Current Surgery, Nov.-Dec., pp. 423-427, 1990.
230. Bregg K, and Vaughan ED Jr: Acute and chronic cellular, tissue, and systemic effects of ESWL. AUA Update Series, Les-son 4, Volume X, 1991.
231. Vaughan ED Jr, and Sosa RE: Hypertension and hydronephrosis. AUA Update Series, Lesson 10, Volume X, 1991.
232. Braren V, Vaughan ED Jr, Mostofi FK, Pennington RD, Salvatierra O, Wein AJ: Long range plan of the National Kidney and Urologic Diseases Advisory Board. J Urol (Editorial), 145:567, 1991.
233. Vaughan ED Jr, Kane M, Fields D: Pharmacologic management of benign prostatic hyperplasia. AUA Update Series, Vol. X, Lesson, 33, 1991.
234. Yon Lutterotti N, Gulmi FA, Marion DN, Vaughan ED Jr, Laragh JH, Sealey JE: Increased plasma prorenin but not renin after bilateral ureteral ligation in dogs. Kid. Intern., 39:901-908, 1991.
235. Spencer JR, Torrado T, Sanchez RS, Vaughan ED Jr, Imperato McGinley J: Effects of flutamide and finasteride on rat tes-ticular descent. Endocrinology, 129(2):741-748, 1991.
236. Felsen D, Frye S, Vaughan ED Jr: Inflammatory mediators and interstitial cystitis. Seminars in Urol., 9(2):102-107, 1991.
237. Vaughan ED Jr, and Walsh PC: Guest editorial: Prostate health council. Urology, 37(5):501, 1991.
238. The MK-906 (Finasteride) Study Group (Bracken B, Geller J, Imperato-McGinley J, Vaughan ED Jr, Gormley GJ, Stoner E, Moore E, and Gregg H): One year experience in the treatment of benign prostatic hyperplasia with finasteride. J. of Androl., 12(6):372-375, 1991.
239. Rodman JS, and Vaughan ED Jr: Chemolysis of urinary calculi. AUA Update Series, Vol. XI, Lesson 1, 1992.
240. Imperato-McGinley J, Sanchez RS, Spencer JR, Yee B, Vaughan ED Jr.: Comparison of the effeects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: Dose-response studies. Endocri-nology, 131(3):1149-1156, 1992.
241. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughan ED Jr, Pappas F, Taylor A, Binkowitz B, Ng J (for the Finasteride Study Group): The effect of finas-teride in men with benign prostatic hyperplasia. N. Eng. J. Med., 327:1185-1191, 1992.
242. Imperato-McGinley J, Gautier T, Zirinsky K, Hom T, Palomo O, Stein E, Vaughan ED Jr, Markisz JA, Ramirez de Arellano E, Kazam E.: Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency. J. of Clin. Endocrinol. and Metab., 75(4):1022-1026, 1992.
243. Schlegel PN, Matthews GJ, Aulitzky WK, Cheng CY, Chen C L C, Saso L, Goldstein M, Janne OA, Bardin CW, Vaughan ED Jr: Clusterin production in the obstructed rabbit kidney: Correlations with loss of renal function. JASN, 3:1163-1171, 1992.
244. Vaughan ED Jr: Imaging of the adrenal gland. World J Urol., 10:190-197, 1992.
245. Vaughan ED Jr (Editorial Comment): The history of research training and career awards in urologic science supported in the National Institute of Diabetes and Digestive and Kidney Diseases. J. Urol., 148:894, 1992.
246. Breslin D, Fields DW, Chou T-C, Kane M, Vaughan ED Jr, Felsen D: Medical management of benign prostatic hyperplasia: A canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonists in the prostate. J. of Urol., 149:395-399, 1993.
247. Cerfolio RJ, Vaughan ED Jr, Brennan TG, and Hirvela ER: Accuracy of computed tomography in predicting adrenal tumor size. Surg Gynecol Obstet, 176:307-309, 1993.
248. Perlmutter A, Miller L, Trimble LA, Marion DN, Vaughan ED Jr, Felsen D: Toradol, a NSAID used for renal colic, de-creases renal perfusion and ureteral pressure in a canine model of unilateral ureteral obstruction. J Urol, 149:926-930, 1993.
249. Ulick S, Blumenfeld JD, Atlas SA, Wang JZ, and Vaughan ED Jr.: The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J of Clin Endocrinol and Metab., 76:873-878, 1993.
250. Spencer JR, Vaughan ED Jr, and Imperato-McGinley J: Studies of the hormonal control of postnatal testicular descent in the rat. J of Urol., 149:618-623, 1993.
251. Perlmutter AP, and Vaughan ED Jr: Prostatic heat treatments for symptomatic BPH. A.U.A. Update Series, Lesson 36, Vol. XII, 1993.
252. Eid JF, Rosenberg P, Rothaus K, Mininberg DT, Hoffman L, Vaughan ED Jr: Use of tissue expanders in final reconstruction of infrapubic midline scar, mons pubis and vulva following bladder exstrophy. Urology, 41:426-430, 1993.
253. Vaughan ED Jr and Perlmutter A: An evolving picture: albeit hazy. Editorial, J. Urol., 150:1622-1623, 1993.
254. Brady K, McCarron JP, Vaughan ED Jr, Javidian P.: Case report: Benign Schwannoma of the retroperitoneal space. J. Urol., 150:179-181, 1993.
255. Spencer JR, Steckel J, May M, Marion D, Hernandez K, Vaughan ED Jr.: Histological and bateriological findings in long term ileocystoplasty and colocystoplasty in the rat. J. of Urol., 150:1321-1325, 1993.
256. Felsen D, Ernsberger P, Sutaria PM, Nijat RJ, Nguyen P, May M, Breslin DS, Broder S, Marion DN and Vaughan ED Jr: Identification, localization and functional analysis of imidazoline and -adrenergic receptors in canine prostate. J. Pharm. Exp. Ther., 268:1063-1071, 1994.
257. Felsen D, Frye S, Trimble LA, Bavendam TG, Parsons CL, Sim Y, and Vaughan ED Jr: Inflammatory mediator profile in urine and bladder wash fluid of patients with interstitial cystitis. J. Urol., 152:355-361, 1994.
258. Stoner E, and the Finasteride Study Group: Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. Arch Intern Med., 154:83-88, 1994.
259. Stoner E, and the Finasteride Study Group: Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia. Urology, 43:284-294, 1994.
260. Uzzo RG, Libby DM, Vaughan ED Jr, and Levey SH: Coexisting lymphangioleiomyomatosis and bilateral angiomyolipomas in a patient with tuberous sclerosis. J Urol., 151:1612-1615, 1994.
261. Uzzo RG, Poppas DP, Schuman RW, and Vaughan ED Jr: An unusual cause of duodenal obstruction: Ureteropelvic junction obstruction and the renoalimentary relationship. Case Report. Urology, 44:433-436, 1994.
262. Vaughan ED Jr, and Girardi SK: Current approaches to the diagnosis and treatment of prostate cancer. Directions in Psy-chiatry, Vol. 14, Lesson 24, November 30, 1994.
263. Blumenfeld JD, Sealey JE, Schlussel Y, Vaughan ED Jr, Sos TA, Atlas SA, Muller FB, Acevedo R, Ulick S and Laragh JH: (Letter to Editor). Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med., 121:877-885, 1994.
264. Vaughan ED Jr: Editorial. Localized prostatic cancer: Clinical concerns. Submitted to J. Urol., 152:1922, 1994.
265. Jarrett TW and Vaughan ED Jr: Accuracy of computerized tomography in the diagnosis of colovesical fistula secondary to diverticular disease. J Urol., 153:44-46, 1995.
266. Uzzo RG and Vaughan ED Jr: Biopsy of lesions of the male genitourinary tract. Surg Oncol Clin of North Am: 4:137-156, 1995.
267. Lemack GE, Poppas DP and Vaughan ED Jr: Urologic causes for gynecomastia: Approach to diagnosis and management. Urology, 45:313-319, 1995.
268. Blumenfeld JD, Vaughan ED Jr, Laragh JH: (In response to Letter to Editor) Diagnosis and treatment of primary hyperaldos-teronism. Ann. Intern Med., 122:801, 1995.
269. Vaughan ED Jr: Editorial Overview: New Techniques in the Diagnosis and Management of Prostate Cancer. Seminars in Urology, 13:95, 1995.
270. Vaughan ED Jr: Commentary on the renal resistive index. J Urol., Vol. 154(3):921, 1995.
271. Perlmutter AP, Vaughan ED Jr: Editorial Comment. Uses and limitations of prostate-specific antigen. J. of Clin. Outcomes Mngmnt (JCOM), 2(4):43-44, 1995.
272. Gulmi FA, Matthews GJ, Marion D, von Lutterotti N, and Vaughan ED Jr: Volume expansion enhances the recovery of renal function and prolongs the diuresis and natriuresis after release of bilateral ureteral obstruction: A possible role for atrial natri-uretic peptide. J. Urol., 153:1276-1283, 1995.
273. Nassir Y, Regunathan S, Reis DJ, Vaughan ED Jr, Felsen D: Castration of rats up-regulates the imidazoline receptor in pros-tate. Annals NY Acad Sci., 763:174-177, 1995.
274. Vaughan ED Jr: Changing of the guard. Seminars in Urology, 1995.
275. Perlmutter AP, Lopez M, Vaughan ED Jr: Creation of a volume lesion in the dog prostate using neodymium:YAG laser co-agulation: Concepts for clinical treatment. Lasers in Surg and Med., 17:59-63, 1995.
276. Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC and Vaughan ED Jr: The influence of prostate size on cancer detection. Urology, 46:831-836, 1995.
277. Moore E, Bracken B, Brenner W, Geller J, Imperato-McGinley J, McConnell J, Roy J, Tenover L, Vaughan ED Jr, Pappas F, Cook T, Gormley G, Stoner E: Proscar: Five year experience. Eur Urol., 28:304-309, 1995.
278. Muschter R, Perlmutter AP, Anson K, Sroka R, Vargas JC, Jahnan P, Yalavac H, Razvi HA, Vaughan ED Jr, and Hofstetter A: Experimental investigations to evaluate the use of semiconductor lasers in interstitial laser coagulation of the prostate - Initial results. Lasermedizin, 11:8-14, 1995.
279. Muschter R, Perlmutter AP, Anson K, Sroka R, Vargas JC, Jahnan P, Yalavac H, Razvi HA, Vaughan ED Jr, and Hofstetter A: Experimentelle untersuchungen zur eignung von halbleiterlasern for die interstitielle laserkoagulation der prostata - erste ergebnisse. Lasermedizin, 11:150-156, 1995.
280. Hyacinthe L, Jarrett T, Gordon C, Vaughan ED Jr, and Whalen G: Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin-related peptide (GRGDS). Ann. Surg. Onc., 2:450-456, 1995.
281. Vaughan ED Jr: Editorial comment: Renal and adrenal sparing surgery for patients with primary aldosteronism and primary reninoma. J Urol., 153:1785-1786, 1995.
282. Uzzo RG, Herzlinger DA and Vaughan ED Jr: Prostate development: Hormonal and cellular considerations. AUA Update Series, Lesson 1, Vol. XV, 1996.
283. Vaughan ED Jr, and Lepor H: Medical management of BPH (Parts I and II). AUA Update Series, Lessons 3 and 4, Vol. XV, 1996.
284. Regunathan S, Nassir Y, Sundaram K, Vaughan ED Jr, Reis DJ, Felsen D: Expression of I2 imidazoline sites in rat prostate. Effect of castration and aging. Biochem. Pharmacol., 51:455-459, 1996.
285. Vaughan ED Jr, Ascheim RS, Berardo JL, Karibian L, Levine JK, Faup DS: Cornell Medical College: Developing an MSO strategy. Clinical Practice (Assoc. Of Am. Med. Coll.): Winter/Spring, Vol. 9, No. 1, pp. 21-25, 1996.
286. Razvi HA, Martin TV, Sosa RE and Vaughan ED Jr: Endourologic management of complications of urinary intestinal diver-sions. A.U.A. Update Series, Vol. XV, Lesson 22, pp. 174-179, 1996.
287. Wright EJ, McCaffrey TA, Robertson AP, Vaughan ED Jr, Felsen D: Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-. Lab. Invest., 74:528-537, 1996.
288. Razvi HA, Fields D, Vargas JC, Vaughan ED Jr, Sosa RE: Oliguria during laparoscopic surgery: Evidence for direct renal parenchymal compression as an etiologic factor. J Endourol., 10:1-4, 1996.
289. Schulsinger DA, Felsen D, Marion DN, Vaughan ED Jr: Expression, localization and inhibition of inducible nitric oxide syn-thase (iNOS) following unilateral ureteral obstruction (UUO) in rat kidney. Surgical Forum, 47:800-802, 1996.
290. Vaughan ED Jr: Diagnosis of surgical adrenal disorders. AUA Update Series, Vol. XVI, Lesson 39, pp.306-311, 1997.
291. O'Connor, LT Jr, Vaughan, ED Jr, Felsen D. In vivo cystometric evaluation of progressive bladder outlet obstruction in rats. J. Urol., 158:631-635, 1997.
292. Vaughan ED Jr., Sosa RE: Renovascular hypertension: Diagnostic strategies and management. AUA Update Series, Vol. XVII, Lesson 4, pp.26-31, 1997.
293. Vaughan ED Jr: Editorial Comment: Renal medicine and renal transplantation. Current Opinion in Urology, 8:111-112, 1998.
294. Vaughan ED Jr.: Renovascular hypertension. Current Opinion in Urology, 8:125-128, 1998.
295. Choi BB, Vaughan ED Jr, Wantz GE: Advances in abdominal wall hernioplasty. Part I. AUA Update Series, Vol. XVII, Lesson 15, pp. 114-119, 1998.
296. Choi BB, Vaughan ED Jr, Wantz GE: Advances in abdominal wall hernioplasty. Part II. AUA Update Series, Vol. XVII, Lesson 16, pp. 122-127, 1998,
297. Sutaria PM, Ohebshalom M, McCaffrey TA, Vaughan ED Jr, and Felsen D: Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction. Life Sciences 62(21):1965-1972, 1998.
298. Gardner TA, Lemer ML, Schlegel PN, Waldbaum RS, Vaughan ED Jr, Steckel J: Microfocal prostate cancer: Biopsy cancer volume does not predict actual tumor volume. Br J Urol., 81:839-843, 1998.
299. Gulmi FA, Felsen D, Vaughan ED Jr: Management of post-obstructive diuresis. A.U.A. Update Series, Vol. XVII, Lesson 23, pp. 178-183, 1998.
300. Schulsinger DA, Perlmutter AP, Sosa RE, Marion D, Vaughan ED Jr: Temperature monitoring and histological evaluation following acute interstitial renal cryoablation in the canine model. Surgical Forum, 49:680-681, 1998.
301. Vaughan ED Jr: Editorial Comment: Renal Medicine and Renal Transplantation. Current Opinion in Urology, 9: 99-100, 1999.
302. Vaughan ED Jr: Editorial Comment. Renin secreting tumors: Diagnosis, conservative surgical approach and long-term re-sults. J. Urol.
303. Vaughan ED Jr: Editorial Comment. Clinical experience of incidentially-discovered pheochromocytoma. J. Urol.
304. Vaughan ED Jr: Editorial Comment. Myelolipoma of adrenal gland: Report of two cases. Indian J of Urol.
305. Vaughan ED Jr: Diagnosis and management of surgical adrenal disorders. International J of Urol 5:401-417, 1998.
306. Choi BB, Steckel J, Denoto G, Vaughan ED, Jr., Schlegel PN: Preperitoneal Prosthetic mesh hernioplasty during radical ret-ropubic prostatectomy. The J of Urol, 161: 840-843, 1999.
307. Lemack GE, Szabo Z, Urban Z, Boyd CD, Csiszar K, Vaughan ED, Jr., Felsen D: Altered bladder function in transgenic mice expressing rat elastin. Neurology and Urodynamics, 18:55-68, 1999.
308. Teng L, Tucker O, Malacoff C, Vaughan ED Jr, Jacobsen J, Fahey TJ III: Telomerase activity in the differentiation of benign and malignant adrenal tumors. Surgery, 124: 1123-7, 1998.
309. Vaughan ED Jr: Editorial Comment: Diagnosis and Treatment of Adrenal Disorders. 圀漀爀氀搀 䨀漀甀爀渀愀氀 漀昀 唀爀漀氀漀最礀Ⰰ 㜀㨀㈀Ⰰ 㤀㤀㤀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㌀ ⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀吀攀攀最攀爀 匀Ⰰ 倀愀瀀愀渀椀挀漀氀愀漀甀 一Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䌀甀爀爀攀渀琀 䌀漀渀挀攀瀀琀猀 椀渀 椀洀愀最椀渀最 漀昀 愀搀爀攀渀愀氀 洀愀猀猀攀猀⸀ 圀漀爀氀搀 䨀漀甀爀渀愀氀 漀昀 唀爀漀氀漀最礀Ⰰ 㜀㨀 ㌀ⴀ㠀Ⰰ 㤀㤀㤀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㌀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀䈀氀甀洀攀渀昀攀氀搀 䨀䐀Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䐀椀愀最渀漀猀椀猀 愀渀搀 琀爀攀愀琀洀攀渀琀 漀昀 瀀爀椀洀愀爀礀 愀氀搀漀猀琀攀爀漀渀椀猀洀⸀ 圀漀爀氀搀 䨀漀甀爀渀愀氀 漀昀 唀爀漀氀漀最礀Ⰰ 㜀㨀 㔀ⴀ㈀Ⰰ 㤀㤀㤀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㌀㈀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 匀甀爀最椀挀愀氀 伀瀀琀椀漀渀猀 昀漀爀 漀瀀攀渀 愀搀爀攀渀愀氀攀挀琀漀洀礀⸀ 圀漀爀氀搀 䨀漀甀爀渀愀氀 漀昀 唀爀漀氀漀最礀Ⰰ 㜀㨀 㐀 ⴀ㐀㜀Ⰰ 㤀㤀㤀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㌀㌀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀匀栀椀挀栀洀愀渀 匀䨀Ⰰ 䠀攀爀渀搀漀渀 匀䌀䄀Ⰰ 匀漀猀愀 刀䔀Ⰰ 圀栀愀氀攀渀 䜀䘀Ⰰ 䴀愀挀䘀椀氀氀椀瘀爀愀礀 䐀䌀Ⰰ 䴀愀氀挀栀漀昀昀 䌀䐀Ⰰ 嘀愀甀最栀愀渀 䔀䐀㨀 䰀愀琀攀爀愀氀 琀爀愀渀猀瀀攀爀椀琀漀渀攀愀氀 氀愀瀀愀爀漀猀挀漀瀀椀挀 愀搀爀攀渀愀氀攀挀琀漀洀礀⸀ 圀漀爀氀搀 䨀漀甀爀渀愀氀 漀昀 唀爀漀氀漀最礀Ⰰ 㜀㨀 㐀㠀ⴀ㔀㌀Ⰰ 㤀㤀㤀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㌀㐀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀匀挀栀甀氀猀椀渀最攀爀 䐀䄀Ⰰ 匀漀猀愀 刀䔀Ⰰ 倀攀爀氀洀甀琀琀攀爀 䄀倀Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䄀挀甀琀攀 愀渀搀 挀栀爀漀渀椀挀 椀渀琀攀爀猀琀椀琀椀愀氀 挀爀礀漀琀栀攀爀愀瀀礀 漀昀 琀栀攀 愀搀爀攀渀愀氀 愀猀 愀 琀爀攀愀琀洀攀渀琀 洀漀搀愀氀椀琀礀⸀ 圀漀爀氀搀 䨀漀甀爀渀愀氀 漀昀 唀爀漀氀漀最礀Ⰰ 㜀㨀㔀㤀ⴀ㘀㐀Ⰰ 㤀㤀㤀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㌀㔀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀匀挀栀甀氀猀椀渀最攀爀 䐀䄀Ⰰ 匀漀猀愀 刀䔀Ⰰ 倀攀爀氀洀甀琀琀攀爀 䄀倀Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䄀挀甀琀攀 愀渀搀 挀栀爀漀渀椀挀 椀渀琀攀爀猀椀琀椀愀氀 挀爀礀漀琀栀攀爀愀瀀礀 漀昀 琀栀攀 愀搀爀攀渀愀氀 愀猀 愀 琀爀攀愀琀ⴀ洀攀渀琀 洀漀搀愀氀椀琀礀⸀ 䨀 䔀渀搀漀甀爀漀氀漀最礀Ⰰ ㌀㨀㐀㨀㈀㤀㤀ⴀ㌀ ㌀Ⰰ 㤀㤀㤀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㌀㘀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀倀栀椀氀氀椀瀀猀 䄀䈀䴀Ⰰ 䈀椀渀猀戀甀爀最 䈀夀Ⰰ 匀栀椀渀 匀䨀Ⰰ 匀漀猀氀漀眀 刀Ⰰ 䬀漀 , Poppas DP: Laser Welding for Vascular Anastomosis Using Albu-min Solder: An Approach for MID-CAB. Lasers in surgery and medicine 24:264-268, 1999.
317. Scherr DS, Vaughan ED Jr., Wei J, Chung M, Felsen D, Allbright R, Knudsen BS. BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy. J Urol 162:12-16, 1999. Erratum in: J Urol 162:503, 1999.
318. Poppas DP, Hubbard JR, Rodgers L, Malhotra V, Workman EA, Bremer S, Kirman I, Schlegel PN, Vaughan ED Jr: Reduc-tion of preoperative anxiety in patients undergoing radical prostatectomy using audio stimulation. Submitted.
319. Vaughan ED Jr.: Forward to: Shared Care for Prostatic Diseases,by Kirby, Eds: Fitzpatrick, Kirkpatrick, Kirby Fitzpatrick, submitted.
320. Vaughan ED Jr.: Renal medicine and renal transplantation (editorial). Current Opinion in Urology 1999 Mar;9(2):99-100.
321. Miyajima A, Chen J, Kirman I, Poppas DP, Vaughan ED Jr., Felsen D: Interaction of nitric oxide and transforming growth factor-beta-1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J Urol 164:1729-1734, 2000.
322. Miyajima A, Chen J, Lawrence C, Ledbetter S, Pigato J, Lemer M, Stern J, Poppas DP, Vaughan ED Jr, Felsen D: Antibody to TGF-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kid Int, 58:2301-2313,2000.
323. Hochberg D, Johnson CW, Chen J, Cohen D, Stern J, Vaughan ED Jr., Poppas DP, Felsen D: Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase. Lab Invest 80:1721:1728, 2000.
324. Miyajima A, Chen J, Poppas DP, Vaughan ED Jr., Felsen D. Role of nitric oxide in renal tubular apoptosis of unilateral ure teral obstruction. Kid.Int.59:1290-1303, 2001.
325. Canes D, Konstantin W, Scherr DS, Hoda S, August P, Vaughan ED Jr. Metastatic paraganglioma to the jejunum. Submitted, J of Urol, 2001.
326. Gmyrek GA, Walburg M, Webb CP, Yu HM, You X, Vaughan ED Jr., Wande Woude GF, Knudsen BS. Normal and malig-nant prostate epithelial cells differ in their response to HGF/SF. Submitted J Urol, 2001.
327. Tash JA, David SG, Vaughan ED Jr., Herzlinger DA. Fibroblast growth factor-7 regulates stratification of the bladder urothe-lium. J Urol 166:2536-254l,2001.
328. Scherr D, Pitts WR, Vaughan ED Jr. Diethylstilbesterol (DES) Revisited: Androgen deprivation, osteoporosis and prostate cancer. J Urol 167:535-538, 2002.
329. Sosa RE, Vaughan ED Jr., Editorial, Laparoscopic Nephrectomy by Ralph V. Clayman et al. J Urol 176:863,2002.
330. Vaughan ED Jr., Editorial, Classic Articles, AUA Centennial Issue, J Urol 167:821, 2002.
331. Cooper KL, Wei JT and Vaughan ED Jr: Spontaneous bladder perforation secondary to pyocystis. Submitted to J. Urology, 2002.
332. Danziger M, Kohan A, Vaughan ED Jr, Felsen D. Changes in bladder function and extracellular matrix in the aging female rat. Submitted, Urology, 2002.
333. OConnor LT Jr, Vaughan ED Jr, Felsen D: Epithelial localization and expression of transforming growth factor- ligand and receptor in normal and obstructed bladder suggests a role in urothelial homeostasis. Submitted, J Urol, 2002.
334. Kohan A, Danziger M, Vaughan ED Jr, Felsen D. Effect of aging on bladder function and the response to outlet obstruction in female rats. Submitted, J Urol, 2002.
335. Felsen D, Schulsinger D, Gross SS, Kim FY, Marion D, Vaughan ED Jr. Renal hemodynamics and ureteral pressure changes in response to ureteral obstruction: Role of nitric oxide. Submitted, J Urol, 2002.
336. Boorjian SA, Cohen M, Tickoo SK, Vaughan ED Jr., Schlegel PN. Bilateral renal cell tumors: A forty-year experience. Sub-mitted, 2002.
337. Stern JM, Chen J, Silver RB, Poppas DP, Vaughan ED Jr., Felsen D. The dopamine receptor, TGF-B and nitric oxide: Novel interactions in UUO. Submitted, Am J Physiol, 2002.
338. Vaughan ED Jr., McLeod DG. Storm over screening for prostate specific antigen. Letter to Editor, Brit Med J 324:1392,2002.
339. Smith EB, Vaughan ED Jr., Bloom DA, Belt E. Edward Lawrence Keyes: A founder of modern Genito-urinary surgery, Sub-mitted, J Urol, 2002.
340. Smyth GP, Yan ZP, Duff M, Maddali S, Masuda T, Jacobs F, Vaughan ED Jr., Stapleton PP, Daly JM. Cyclo-oxygenase 2 is over-expressed in renal cell cancer compared with normal kidney. BJU International 90 (1):28,2002.
341. Vaughan ED Jr, Imperato-McGinley J, McConnell J, Matsumoto AM, Bracken B, Roy J, Sullivan M, Pappas F, Cook T, Daurio C, Meehan A, Stoner E, Waldstreicher J. Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology 60: 1040-1044, 2002.
342, Knudsen BS, Gmyrek GA, Inra J, Scherr DS, Vaughan ED, Nanus DM, Dattan MW, Gerald WL, Vande Woude GF. High expression of the Met receptor in prostate cancer metastasis to bone. Urology 60:1113-1117, 2002.
343. Dasari N, Nori D, Vaughan ED Jr., Parikh S, Shemtov M, Allbright RM, Poli J, Presser J, Osian A. Positive biopsies and bio-chemical outcome after combine external beam radiation therapy and out-patient conformal brachytherapy for clinically local-ized prostate cancer. Radiology 225:365-366, 2002.
344. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughan ED, Ppas F, Taylor A, Binkowitz B, Ng J. Finasteride Study Group. The effect of finasteride in men with benign prostatic hyperplasia. 1992. [Biography. Classical Article. Historical Article. Journal Article] J Urol 167:1102-1108, 2002.
345. Vaughan ED Jr. Long-term experience with 5-alpha-reductase inhibitors. New Perspectives on BPH. Reviews in Urology. Med Reviews 5:S28-S33, 2003.
346. Vaughan ED Jr. Editorial: Medical management of benign prostatic hyperplasia: Are two drugs better than one? N Engl J Med, 2003.
347. Stern J, Chen J, Silver R, Poppas D, Vaughan ED Jr., Felsen D. The dopamine receptor IGF-b and nitric oxide: Novel interac-tions in unilateral ureteral obstruction. Amer J Physiology, 2003.
348. Scherr DS, Ng C, Munver R, Sosa RE, Vaughan ED Jr., Del Pizzo J. Practice patterns among urologic surgeons treating lo-calized renal cell carcinoma in the laparoscopic age: Technology versus oncology. Urology 62:1007-1011, 2003.
349. Smith EB, Vaughan ED, Belt ES, Bloom DA. Edward Lawrence Keyes: A pivotal early specialist in modern genitourinary surgery. Urology 62:968-972, 2003.
350. Felsen D, Dardashti K, Osted M, Lemer ML, Gross SS, Chen J, Vaughan ED Jr., Poppas, D: Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction. J Urol 169:1569-1572, 2003.
351. Ito K, Chen, J, El Chaar M, Stern JM, Seshan SV, Khodadadian JJ, Hyman MJ, Poppas DP, Vaughan ED Jr., Felsen D: Re-nal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction (UUO) in adult rats. In press, 2003.
352. Ito K, Chen J, Khodadadian JJ, Seshan SV, Eaton C, Zhao X, Poppas DP, Vaughan ED Jr., Lipkowitz M, Felsen D: Lipo-some-mediated transfer of nitric oxide synthase gene improves renal function in ureteral obstruction in rats. In press, 2003.
353. Ito K, Chen J, Vaughan ED Jr., Seshan SV, Poppas DP, Felsen D: Dietary L-arginine supplementation improves the glomeru-lar filtration rate and renal blood flow after 24 hours of unilateral ureteral obstruction in rats. J Urol 171:926-930, 2004.
354. David SC, Cebrian C, Vaughan ED Jr., Herzlinger D. c-kit and ureteral peristalsis. Submitted, 2004.
355. Nori D, Reddy NMS, Vaughan ED Jr., Shemtov MM: The impact of technological advances on the evolution of 3D confor-mal brachytherapy for early prostate cancer. Technology in Cancer Research & Treatment 3:335-345, 2004.
356. Vaughan ED Jr., Marion D, Poppas DP, Felsen D. Pathophysiology of unilateral ureteral obstruction studies from Charlottes-ville to New York. Submitted Festschrift, J Urol, 2004.
357. Tarter TH, Vaughan ED Jr.: Inhibitors of 5-alpha-reductase in the treatment of benign prostatic hyperplasia. In press, 2004.
358. Boyle P, Robertson C, Vaughan ED, Fitzpatrick JM. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. BJU Int. 2004 Jul;94(1):83-8.
359. Sandhu J, Vaughan ED Jr: Pharmacological Management of Benign Prostatic Hyperplasia: A Review Combination Treat-ment. In press, 2005.
360. Schiff JD, Palese M, Vaughan ED Jr, Sosa RE: Laparoscopic Versus Open Partial Nephrectomy in 125 Consecutive Patients, In press, 2005.
Publications Cont.: Abstracts
1. Vaughan ED Jr, Gillenwater JY and Sorenson EJ: Mechanism of acute hemodynamic response to ureteral occlusion. IV In-ternational Congress of Nephrology, Stockholm, 1969.
2. Gillenwater JY, Westervelt FB, Vaughan ED Jr and Carter CB: Impaired renal function in unilateral hydronephrosis. IV International Congress of Nephrology, Stockholm, 1969.
3. Buhler FR, Baer L, Vaughan ED Jr, Brunner HR and Laragh JH: Inhibition of renin secretion by propranolol: A specific treatment for renal hypertension? J. Clin. Invest., 51:17a, 1972.
4. Buhler FR, Baer L, Jacob G, Vaughan ED Jr, Pattner AM, Sotello JE, Brunner HR and Laragh JH: Inhibition of renin secre-tion by propranolol: Its diagnostic and therapeutic value in essential, renovascular, malignant and endstage renal hypertension. V. International Congress of Nephrology, Mexico City, 1972.
5. Vaughan ED Jr, Buhler FR, Gavras I, Brunner HR, Baer L and Laragh JH: Spirolactone compared to diuretic therapy in analysis and treatment of normal and low renin hypertensions. Circulation 66:II 83, 1972.
6. Johnson PM, Vaughan ED Jr, Beg K, Esser PD and Laragh JH: Quantitative dynamic renal imaging as a screening test for potentially curable hypertension. J. Nuclear Med., 14:628, 1973.
7. Ayers C, Johnson C, Vaughan ED Jr, Harris R and Yancey M: Effect of 1 SAR8 angiotensin (P 113) on plasma renin and renal pressure in acute dog renovascular hypertension. Circulation 48:IV 71, 1973.
8. Gavras H, Brunner HR, Laragh JH, Vaughan ED Jr and Keenan R: Angiotensin II blockade, renin secretion and sodium bal-ance in hypertensive man. Circulation 48:IV 167, 1973.
9. Sarstedt CA, Vaughan ED Jr and Peach MJ: Angiotensin antagonists on aldosterone excretion in conscious rats. The Phar-macologist 16:296, 1974.
10. Johnson PM, Beg K, Keim HJ, Vaughan ED Jr and Laragh JH: Quantitative dynamic renal imaging in hypertension. Invest. Radiol., 9:326, 1974.
11. Kimbrough HM Jr, Vaughan ED Jr, Carey RM and Ayers CR: Effect of intrarenal angiotensin II (AII) on renal function in conscious dogs. Clin. Res., 23:55A, 1975.
12. Kimbrough HM Jr, Vaughan ED Jr, Carey RM and Ayers CR: Role of intrarenal angiotensin II on renal function in conscious dogs. Clin. Res., 23:366A, 1975.
13. Keim HJ, Beg K, Johnson PM, Vaughan ED Jr and Laragh JH: A screening test for renovascular hypertension using renal imaging. VI International Congress of Nephrology, 439, 1975.
14. Vaughan ED Jr, Kimbrough HM Jr, Carey RM and Ayers CR: Intrarenal role of angiotensin II for control of glomerular fil-tration rate and renal blood flow during sodium restriction in conscious dogs. VI International Congress of Nephrology, 487, 1975.
15. Sarstedt CA, Larner A, Vaughan ED Jr and Peach MJ: Changes in adrenal cortical and cardiovascular responses to angio-tensin induced by sodium deprivation. The Pharmacologist 17:235, 1975.
16. Carey RM, Reid RA, Ayers CR, Lynch SS, McLain WL and Vaughan ED Jr: Prevalence of labile and sustained hypertension in Charlottesville, Virginia. Circulation 52:Supp. 2, 54, 1975.
17. Bolton WK and Vaughan ED Jr: A comparative study of open surgical and percutaneous renal biopsies. Kid. Int., 8:407, 1975.
18. Bolton WK and Vaughan ED Jr: A comparative study of open surgical and percutaneous renal biopsies. Clin. Res., 24:35A, 1976.
19. Ayers CR, Vaughan ED Jr, Katholi RE, Carey RM and Kimbrough HM Jr: Mechanism of renal arteriolar vasoconstriction and negative renin feedback in chronic one kidney dog Goldblatt hypertension. Clin. Res., 24:392A, 1976.
20. Katholi RE, Carey RM, Ayers CR and Vaughan ED Jr: Production of sustained hypertension by chronic in trarenal norepi-nephrine infusion in conscious dogs. Clin. Res., 24:468A, 1976.
21. Vaughan ED Jr, Carey RM, Ackerly JA, Peach MJ and Ayers CR: Hyperrenemia: A limitation of diuretic anti hypertensive potential. Clin. Res., 24:274A, 1976.
22. Katholi RE, Carey RM, Ayers CR and Vaughan ED Jr: Production of sustained hypertension by chronic intrarenal norepi-nephrine infusion in conscious dogs. Circulation 53 54:II 176, 1976.
23. Ayers CR, Vaughan ED Jr, Katholi RE, Carey RM and Kimbrough HM Jr: Mechanism of renal arteriolar vasoconstriction and negative renin feedback in chronic one kidney dog Goldblatt hypertension. Circulation 53 54:II 176, 1976.
24. Carey RM, Vaughan ED Jr, Ackerly JA, Peach MJ and Ayers CR: Mechanism of the pressor effect of Sar1 Ala8 angiotensin II (P113) in man. Circulation 53 54:II 1976.
25. Vaughan ED Jr, Carey RM, Ayers CR, Wellons HA and Tegtmeyer CJ: Saralasin to identify surgically curable renovascular hypertension (RVH): Pitfalls and promises. Kid. Int., 10:537, 1976.
26. Ackerly JA, Carey RM, Peach MJ, Vaughan ED Jr and Epstein RM: Changes in plasma norepinephrine, dopamine B hydroxylase activity and blood pressure induced by diuretic therapy and P113 infusion. Fed. Proc., 36:4103, 1977.
27. Carey RM, Vaughan ED Jr, Peach MJ and Ayers CR: Effect of angiotensin III on blood pressure and aldosterone production in man. Cir. Res., 25:462A, 1977.
28. Ackerly JA, Vaughan ED Jr, Glenn AW and Peach MJ: Formation of (des Asp1)angiotensin I across perfused rat lung. Pharmacologist 19:159, 1977.
29. Carey RM, Vaughan ED Jr, Peach MJ and Ayers CR: Differences in vascular and adrenal cortical responses to angiotensin II and (des Asp1) angiotensin II in man. Circulation 55 56:III 32, 1977.
30. Vaughan ED Jr, Ackerly JA, Lantz CH, Glenn AW and Peach MJ: Formation and circulating level of (des Asp1) angiotensin I in the rat. Circulation 55 56:III 215, 1977.
31. Carey RM, Peach MJ, Vaughan ED Jr and Ayers CR: Effects of renin suppression on responses to angio tensin II and III in man. Clin. Res., 26:361, 1978.
32. Ayers CR, Carey RM and Vaughan ED Jr: The use of angiotensin antagonists in the study of renal function. Proc. VIIth In-ternational Congress of Nephrology 13 32, 1978.
33. Vaughan ED Jr, Carey RM, Ayers CR, Weed WC and Peach MJ: Acute and chronic anti hypertensive action of an orally active converting enzyme inhibitor (SQ 14225) in renal and essential hypertension. Proc. of VIIth International Congress of Nephrology B 24, 1978.
34. Levens NR, Vaughan ED Jr, Peach MJ and Carey RM: Intrarenal angiotensin II regulates renal free water formation in con-scious dogs. Kid. Int., 14:697, 1978.
35. Levens NR, Vaughan ED Jr, Peach MJ and Carey RM: Potentiation of the anti diuretic action of vasopressin by intrarenal angiotensin in conscious dogs. Clin. Res., 26:790A, 1978.
36. Levens NR, Vaughan ED Jr, Peach MJ and Carey RM: Changes in sodium excretion after intrarenal blockage of the renin angiotensin system. 38(3):749, 2752, 1979.
37. Levens NR, Vaughan ED Jr, Peach MJ and Carey RM: Regulation of free water clearance by intrarenal angiotensin II.
38. Carey RM, Levens NR, Vaughan ED Jr, and Peach MJ: Evidence for an antidiuretic action of intrarenal angiotensin.
39. Carey RM, Vaughan ED Jr, Howards SS: Unilateral surgical approach to adrenal adenomas after non-invasive preoperative diagnosis and localization. AUA 75th Annual Meeting, San Francisco, CA, May, p. 114, Abstract #153, 1980.
40. Sos TA, Sniderman KW, Pickering TG, Case DB, Vaughan ED Jr: Percutaneous transluminal renal angioplasty: blood pres-sure and renin responses in patients with renovascular hypertension. AUA 75th Annual Meeting, San Francisco, CA, May, p. 116, Abstract #158, 1980.
41. Leslie BR, Vaughan ED Jr, Case DB: Captopril therapy of hypertension in end-stage renal disease (ESRD). AUA 75th An-nual Meeting, San Francisco, CA, May, p. 116, Abstract #159, 1980.
42. Kleinert HD, Leslie BR, Laragh JH and Vaughan ED Jr: Comparative effects of infusions of isotonic sodium chloride, manri-tol, undextrose in normotensive anephric rats. Fed. Proc., 40:605, 1981.
43. Atlas SA, Letcher RL, Case DB, Pickering TG, Resnick LR, Vaughan ED Jr, Sealey JE and Laragh JH: Aldosterone re-sponse to upright posture and converting enzyme inhibition in primary aldosteronism. Clin. Res., 29(2):565A, 1981.
44. Parnell JP, Marshall VF, Vaughan ED Jr: Primary management of urinary stress incontinence by the Marshall Marchetti Krantz vesicouretheropexy. AUA 76th Annual Meeting, Boston, MA, May, p. 134, Abstract #171, 1981.
45. Israel AR, Cahill PC, Mininberg DT, Vaughan ED Jr: Validation of the diuretic renogram with simultaneous intrapelvic pres-sure monitoring. AUA 76th Annual Meeting, Boston, MA, May, p. 194, Abstract #413, 1981.
46. Vaughan ED Jr, Blumberg AL, Morrison AR, Thornton F: Thromboxane A potential mediator of the increased renal vascular resistance found in obstructive uropathy. AUA 76th Annual Meeting, Boston, MA, May, p. 194, Abstract #415, 1981.
47. Sniderman KW, Saddekin S, Weiner M, Beinart C, Pickering TG, Case DB, Vaughan ED Jr and Laragh JH: Renal vein renin assay and digital intravenous angiography in patients with renovascular hypertension. Clin. Res., 30:693A, 1982.
48. Sos TA, Sniderman KW, Saddekin S, Weiner M, Beinart C, Pickering TG, Case DB, Silane M, Vaughan ED Jr and Laragh JH: Renal angioplasty for relief of hypertension. Clin. Res., 30:693A, 1982.
49. Vaughan ED Jr, Albanese CT, Marion DN, Wong PY-K: Thromboxane A2 (TxA2) inhibition partially reverses the increased renal vascular resistance (RVR) found at 24 hours of complete unilateral ureteral occlusion (UUO) in the dog. AUA 77th Annual Meeting, Kansas City, MO, May, p. 139, Abstract #248, 1982.
50. Weisman SM, Felsen D and Vaughan ED Jr: Effects of dietary sodium on renal cortical and medullary prostaglandin synthe-sis. Fed. Proc., 42:640, 1983.
51. Schlossberg SM, Finkel ML, Vaughan ED Jr, McCarthy EG: Second consultant opinion for elective urologic surgery. AUA 78th Annual Meeting, Las Vegas, NV, April, p. 215, Abstract #495, 1983.
52. Pickering TG, Case DB, Sos TA, Vaughan ED Jr, Sealey JE and Laragh JH: Unilateral suppression of renin secretion in pa-tients with bilateral renal artery stenosis. Clin. Res., 31(2):517A, 1983.
53. Pickering TG, Sos TA, Harshfield GA, Case DB, Vaughan ED Jr, Sealey JE and Laragh JH: Changes in renin secretion fol-lowing renal angioplasty in hypertensive patients with unilateral renal disease. Clin. Res., 31(2):439A, 1983.
54. Atuk NO, Rudolf L, Mihindu J, Vaughan ED Jr, Turner S and White C: Effect of verapamil (V) on preservation of renal function after ischemia. Kid. Int., 25:339, 1984.
55. Miller I, Riggio RR, Suthanthiran M, Cheigh J, Tapia L, Mouradian J, Stubenbord W, Riehle RA Jr, Williams J, Vaughan ED Jr and Stenzel KH: The impact of renal donation: Long term (clinical and biochemical) follow up of living donors in a single center. Kid. Int., 25:346, 1984.
56. Katz SE, Vaughan ED Jr, Novogrodsky A and Stenzel KH: Induction of differentiation in human renal cell carcinoma lines. J. of Urology/AUA 79th Annual Meeting., Vol. 131, No. 4., Part 2, pp. 130A, Abst. #106, May, 1984.
57. Bander NH, Cordon Cardo C, Finstad CL, Vaughan ED Jr, Whitmore WF Jr, Melamed MR, Oetggen HF and Lloyd JO: Re-sults of the study of human renal cancer with monoclonal antibodies (mAb). J. of Urology/AUA 79th Annual Meeting, Vol. 131., No. 4., Part 2, pp. 178A, Abst. #297, May, 1984.
58. Byrne JC and Vaughan ED Jr: Bladder isometric contraction speed correlates with emptying rate. J. of Urology/AUA 79th Annual Meeting, Vol. 131, No. 4, Part 2, pp. 190A, Abst. #348, May, 1984.
59. Atlas SA, Marion DN, Kleinert HD, Camargo MJ, Laragh JH, Vaughan ED Jr and Maack T: Inhibition of aldosterone and renin release by synthetic atrial natriuretic factor (ANF). Circulation 70:II 332, 1984.
60. Volpe M, Odell G, Kleinert HD, Camargo MJ, Lewicki JA, Laragh JH, Maack T, Vaughan ED Jr and Atlas SA: Synthetic atrial natriuretic factor (ANF) reduces blood pressure and aldosterone in renin dependent renovascular hypertension. Am. Soc. of Neph./Annual Meeting, Dec. 9 12, pp. 104A, 1984.
61. Weisman SM, Felsen D and Vaughan ED Jr: Effect of platelet activating factor (PAF) on renal prostaglandin (PG) release in unilateral ureteral obstruction (UUO). Am. Soc. of Neph./Annual Meeting, Dec. 9 12, pp. 171A, 1984.
62. Maack T, Marion DN, Camargo MJF, Kleinert HD, Laragh JH, Vaughan ED Jr and Atlas SA: Effects of synthetic atrial na-triuretic factor (auriculin) on kidney function and the renin aldosterone system in the dog. Am. Soc. of Neph./Annual Meet-ing, Dec. 9 12, pp. 218A, 1984.
63. Vaughan ED Jr and Sosa RE: Prognostic significance of the level of inferior vena caval involvement by renal cell carcinoma. J. of Urol., 56:86, 1984.
64. Vaughan ED Jr and Mills C: Management of upper ure teric tumours. J. of Urol., 56:86, 1984.
65. Vaughan ED Jr, Schlossberg SM, Finkel ML and McCarthy EG: Second opinion for urologic surgery. J. of Urol., 56:93, 1984.
66. Vaughan ED Jr: Evaluation and management of the hypertensive patient. J. of Urol., 56:94, 1984.
67. Vaughan ED Jr, Parnell JP III, and Marshall VF: Update on the New York Hospital experience with the Marshall Marchetti Krantz procedure. Br. J. of Urol., 56:95, 1984.
68. Imperato-McGinley J, Mininberg D, and Vaughan ED Jr: Studies of the histology of the internal and external genital struc-tures of newborn male rats treated in utero with 5 alpha-reductase inhibitors. Clinical Research 32:2, Abst. p. 266A, April 1984.
69. Imperato-McGinley J, Binienda Z, Arthur A, Mininberg D, and Vaughan ED Jr: Studies of the histology of the internal and external genital structures of newborn rats treated in utero with 5 alpha-reductase inhibitors. American Academy of Pediat-rics, Urology Section, September, 1984.
70. Felsen D and Vaughan ED Jr: Kupffer cells (KC) in culture metabolize both exogenous and endogenous arachidonic acid (AA). Fed Proc., 44:1468, 1985.
71. Weisman SM, Felsen D and Vaughan ED Jr: Platelet activating factor (PAF) is a potent stimulus for renal prostaglandin (PG) release in unilateral ureteral obstruction (UUO). Fed Proc., 44:1821, 1985.
72. Sternberg CN, Yagoda A, Whitmore WF Jr, Fleisher M, Huffman J, Bander NH and Vaughan ED Jr: Pharmacokinetics of intravesical methotrexate (MTX) for superficial bladder tumors. (#1404) Proc. Am. Soc. Clin. Oncol., 26:356, 1985.
73. Loo MH, Marion DN, Vaughan ED Jr, Felsen D: Failure of thromboxane inhibition to improve renal blood flow in dogs with complete unialteral ureteral obstruction. J. Urol/AUA 80th Annual Meeting, Vol. 133, No. 4, Part 2, pp. 129A, Abst. #63, May, 1985.
74. Riehle RA Jr, Fair W, Vaughan ED Jr: Endourologic procedures after extracorporeal shockwave lithotripsy. J. Urol/AUA 80th Annual Meeting, Vol. 133, No. 4, Part 2, pp. 171A, Abst. #230, May, 1985.
75. Tiffany PN, Morse M, Bosl GJ, Whitmore WF Jr, Vaughan ED Jr: Sequential excision of residual thoracic and retroperito-neal masses after chemotherapy for Stage III germ cell tumors. J. Urol/AUA 80th Annual Meeting, Vol. 133, No. 4, Part 2, pp. 245A, Abst. #525, May, 1985.
76. Vaughan ED Jr: Modification of the posterior approach for right adrenalectomy. J. Urol/AUA 80th Annual Meeting, Vol. 133, No. 4, Part 2, pp. 279A, Abst. #662, May, 1985.
77. Fair WR, Riehle R, Vaughan ED Jr: Innovations in urologic surgery: Extracorporeal shock wave lithotripsy (ESWL). J. Urol/AUA 80th Annual Meeting, Vol. 133, No. 4, Part 2, pp. 281A, Abst. #669, May, 1985.
78. Sternberg CN, Yagoda A, Whitmore WF Jr, Fleisher M, Huffman JL, Bander NH and Vaughan ED Jr: Pharmacokinetics of intravesical methotrexate for superficial bladder tumors. J. Urol/AUA 80th Annual Meeting, Vol. 133, No. 4, Part 2, pp. 294A, Abst. #719, May, 1985.
79. Kudlak T, Riehle RA Jr, Malhotra V, Fair W, Vaughan ED Jr: Regional anesthesia for extracorporeal shockwave lithotripsy. J. Urol/AUA 80th Annual Meeting, Vol. 133, No. 4, Part 2, pp. 312A, Abst. #794, May, 1985.
80. Sosa RE, Huffman JL, Riehle RA, Vaughan ED Jr: Ureteropyeloscopy: Pitfalls and early complications of ureteral stone ex-traction. J. Urol/AUA 80th Annual Meeting, Vol. 133, No. 4, Part 2, pp. 312A, Abst. #794, May, 1985.
81. Imperato-McGinley J, and Vaughan ED Jr: Elucidation of the role of dihydrotestosterone in sexual differentiation of the male rat using selective inhibitors of the enzyme 5 alpha-reductase. The Endocrine Society, #3JS, 1985.
82. Weisman SM, Felsen D and Vaughan ED Jr: Platelet activating factor (PAF) receptor antagonists differentially affect PAF and peptide stimulated prostaglandin (PG) release in unilateral ureteral obstruction (UUO). FASEB, April, 1986.
83. Weisman SM, Felsen D, Freund RM and Vaughan ED Jr: Platelet activating factor (PAF) receptor antagonists differentially affect PAF and peptide stimulated prostaglandin (PG) release in unilateral ureteral obstruction (UUO). 6th International Con-ference on Prostaglandins and Related Compounds, 1986.
84. Aronne LJ, Braham RL, Riehle RA Jr, Vaughan ED Jr and Ruchlin H: Cost effectiveness of extracorporeal shock wave lith-otripsy. American Federation for Clinical Research. Clin. Res., 34(2):358A, 1986.
85. Weisman SM, Seniuk S, Corbett M, Sosa RE, Felsen D, Vaughan ED Jr and Resnick LM: The influence of dietary calcium on prostaglandin metabolism in experimental hypertension. 11th Scientific Meeting of the International Society of Hyperten-sion, 1986.
86. Vaughan ED Jr, Marion D, Felsen D and Weisman SM: Evidence against angiotensin II (AII) or thromboxane A2 (TxA2) as mediators of the increased renal vascular resistance (RVR) found following unilateral ureteral occlusion (UUO). 19th Annual Meeting of the American Society of Nephrology, 1986.
87. Weisman SM, Seniuk S, Corbett M, Sosa RE, Felsen D, Vaughan ED Jr and Resnick LM: The effect of dietary cal-cium intake on renal prostaglandin production in experimental hypertension. 19th Annual Meeting of the American Society of Nephrology, 1986.
88. Amberson JB, Vaughan ED Jr, Gray GF, and Naus GJ: Cellular DNA content analysis of adrenocortical tumors and adrenal pheochromocytomas by flow cytometry using paraffin embedded tissue. J. Urol/AUA 81st Annual Meeting, Vol. 135, No. 4, Part 2, pp. 258A, Abst. #616, May, 1986.
89. Riehle RA Jr and Vaughan ED Jr: Chemical and crystalographic analysis of voided stone fragments after ESWL. J. Urol/AUA 81st Annual Meeting, Vol. 135, No. 4, Part 2, pp. 152A, Abst. #193, May, 1986.
90. Nicholson JP, Illig KA, Marion D, Vaughan ED Jr and Laragh JH: Post or extrasynaptic alpha two adrenoceptors helps pre-serve autoregulation in the dog kidney. (#1494) American Heart Association, Circulation Supplement, 74:II 374, 1986.
91. Mellinger B, Vaughan ED Jr, Thompson SL, Goldstein M: Correlation between intracaver-nous papaverine injection and Doppler analysis in impotent men. Presented at the N.Y. Section of the A.U.A. Annual Meeting, Laguna Niguel, California, October, 1986.
92. Carlton CE Jr, Vaughan ED Jr: Visits in urology: Management of urologic innovation. J. Urol/AUA 82nd Annual Meeting, Vol. 137, No. 4, Part 2, pp. 116A, Abst. #50, May, 1987.
93. Somers WJ, Marion DN, Chernesky CE and Vaughan ED Jr: A new model for measuring the effect of alpha adrenergic stimulation on prostatic urethral pressure. J. Urol/AUA 82nd Annual Meeting, Vol. 137, No. 4, Part 2, pp. 128A, Abst. #99, May, 1987.
94. Gorelick JI, Senterfit LB, Vaughan ED Jr: Quantitative 戀愀挀琀攀爀椀愀氀 琀椀猀猀甀攀 挀甀氀琀甀爀攀猀 昀爀漀洀 ㈀ 㤀 爀攀猀攀挀琀攀搀 瀀爀漀猀琀愀琀攀猀㨀 䘀椀渀搀椀渀最猀 愀渀搀 椀洀瀀氀椀挀愀琀椀漀渀猀⸀ 䨀⸀ 唀爀漀氀⼀䄀唀䄀 㠀㈀渀搀 䄀渀渀甀愀氀 䴀攀攀琀椀渀最Ⰰ 嘀漀氀⸀ ㌀㜀Ⰰ 一漀⸀ 㐀Ⰰ 倀愀爀琀 ㈀Ⰰ 瀀瀀⸀ ㌀㘀㘀䄀Ⰰ 䄀戀猀琀⸀ ⌀ 㔀㈀Ⰰ 䴀愀礀Ⰰ 㤀㠀㜀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㤀㔀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀一椀挀栀漀氀猀漀渀 䨀倀Ⰰ 䤀氀氀椀最 䬀䄀Ⰰ 䴀愀爀椀漀渀 䐀一Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀 愀渀搀 䰀愀爀愀最栀 䨀䠀㨀 倀漀猀琀 漀爀 攀砀琀爀愀猀礀渀愀瀀琀椀挀 愀氀瀀栀愀 琀眀漀 愀搀爀攀渀漀挀攀瀀琀漀爀猀 栀攀氀瀀猀 瀀爀攀猀攀爀瘀攀 愀甀琀漀爀攀最甀氀愀琀椀漀渀 椀渀 琀栀攀 搀漀最 欀椀搀渀攀礀⸀ 䌀椀爀挀甀氀愀琀椀漀渀Ⰰ 嘀漀氀⸀ 㜀㐀Ⰰ 匀甀瀀瀀 䤀䤀Ⰰ 㤀㠀㜀⸀ 㰀戀爀⼀㸀㰀戀爀⼀㸀㤀㘀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀䠀攀猀猀攀 䐀䜀Ⰰ 匀椀氀攀渀 䴀䰀Ⰰ 䘀攀氀猀攀渀 䐀Ⰰ 匀攀渀椀甀欀 匀Ⰰ 䌀愀氀瘀愀渀漀 匀Ⰰ 刀栀礀渀攀 䌀Ⰰ 䴀愀爀愀渀漀 䴀Ⰰ 䘀漀渀最 夀Ⰰ 䌀攀爀愀洀椀 䄀Ⰰ 䰀漀眀爀礀 匀䘀 愀渀搀 嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䤀猀漀氀愀琀椀漀渀 愀渀搀 瀀愀爀琀椀愀氀 挀栀愀爀愀挀琀攀爀椀稀愀琀椀漀渀 漀昀 愀 洀愀挀爀漀瀀栀愀最攀 氀椀欀攀 爀攀渀愀氀 挀漀爀琀椀挀愀氀 挀攀氀氀 瀀漀瀀甀氀愀琀椀漀渀⸀ 䨀⸀ 唀爀漀氀⼀䄀唀䄀 㠀㌀爀搀 䄀渀渀甀愀氀 䴀攀攀琀ⴀ椀渀最Ⰰ 嘀漀氀⸀ ㌀㤀Ⰰ 一漀⸀ 㐀Ⰰ 倀愀爀琀 ㈀Ⰰ 瀀瀀⸀ ㈀㠀㐀䄀Ⰰ 䄀戀猀琀⸀ ⌀㐀㠀㠀Ⰰ 䨀甀渀攀Ⰰ 㤀㠀㠀⸀㰀戀爀⼀㸀㤀㜀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀䘀攀氀猀攀渀 䐀Ⰰ 䴀愀爀椀漀渀 䐀一 愀渀搀 嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䤀渀琀攀爀愀挀琀椀漀渀猀 漀昀 瀀氀愀琀攀氀攀琀ⴀ愀挀琀椀瘀愀琀椀渀最 昀愀挀琀漀爀 ⠀倀䄀䘀⤀ 愀渀搀 爀攀渀愀氀 栀攀洀漀搀礀渀愀洀椀挀猀⸀ 䨀⸀ 唀爀漀氀⼀䄀唀䄀 㠀㌀爀搀 䄀渀渀甀愀氀 䴀攀攀琀椀渀最Ⰰ 嘀漀氀⸀ ㌀㤀Ⰰ 一漀⸀ 㐀Ⰰ 倀愀爀琀 ㈀Ⰰ 瀀瀀⸀ ㈀㐀㠀䄀Ⰰ 䄀戀猀琀⸀ ⌀㌀㐀㐀Ⰰ 䨀甀渀攀Ⰰ 㤀㠀㠀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㤀㠀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀䴀攀氀氀椀渀最攀爀 䈀Ⰰ 䬀愀稀愀洀 䔀 愀渀搀 嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䤀渀琀爀愀挀漀爀瀀漀爀愀氀 瀀愀瀀愀瘀攀爀椀渀攀 眀椀琀栀 搀甀瀀氀攀砀 猀漀渀漀最爀愀瀀栀礀 愀渀搀 瀀甀氀猀攀搀 䐀漀瀀瀀氀攀 analysis in the evaluation of the impotent male. J. Urol/AUA 83rd Annual Meeting, Vol. 139, No. 4, Part 2, pp. 327A, Abst. #660, June, 1988.
99. Volpe M, Sosa RE, Atlas SA, Camargo MJ, Sala C, Mueller FB, Vaughan ED Jr and Laragh JH: ANF attenuates hyperten-sion induced by acute unilateral renal artery clipping in rats. Third World Congress on Biologically Active Atrial Peptides, 1988.
100. Crowley AR, Byrne JT, Vaughan ED Jr, Marion DN: The effect of acute obstruction on ureteral function. J. of Urol-ogy/A.U.A. 84th Annual Meeting, Dallas, Vol. 141, No. 4, Part 2, pg. 211A, #165, 1989.
101. Perlmutter AP, Marion DN, Kauff AB, Vaughan ED Jr: The effect of interleukin 2 (IL 2) on renal hemodynamics in dogs. J. of Urology/A.U.A. 84th Annual Meeting, Dallas, Vol. 141, No. 4, Part 2, pg. 212A, #171, 1989.
102. Hesse DG, Silen ML, Felsen D, Seniuk S, Cerami A, Lowry SF, Vaughan ED Jr: Persistent kidney tumor necrosis factor (TNF) production in chronic endotoxemia is associated with a hypoosmotic diuresis and acute renal pathology. J. of Urol-ogy/A.U.A. 84th Annual Meeting, Dallas, Vol. 141, No. 4, Part 2, pg. 252A, #330, 1989.
103. Fried JJ, Mellinger BC, Vaughan ED Jr: Papaverine induced penile blood flow acceleration in impotent men measured by duplex scanning. J. of Urology/A.U.A. 84th Annual Meeting, Dallas, Vol. 141, No. 4, Part 2, pg. 274A, #418, 1989.
104. Mellinger BC, Vaughan ED Jr: Penile blood flow changes in the flaccid and erect state in potent young men measured by duplex sonography/pulsed doppler analysis. J. of Urology/A.U.A. 84th Annual Meeting, Dallas, Vol. 141, No. 4, Part 2, pg. 541A, #1505, 1989.
105. von Lutterotti N, Gulmi FA, Marion DN, Vaughan ED Jr, Sealey JE: Relationship of plasma prorenin to renal function in dogs after bilateral ureteral obstruction. 13th Scientific Meeting of the International Society of Hypertension, 1989.
106. Gulmi FA, Marion DN, Vaughan ED Jr: The role of atrial natriuretic peptide (ANP) in the recovery of renal function after release of bilateral ureteral obstruction (BUO). 22nd Annual Meeting of the American Society of Nephrology, 1989.
107. von Lutterotti N, Gulmi FA, Marion DN, Vaughan ED Jr, Sealey JE: Bilateral ureteral obstruction increases plasma prorenin but not renin in dogs. 62nd Scientific Sessions, American Heart Association, November, 1989.
108. Nicholson JP, Cigarroa J, Ward N, Marion DN, Vaughan ED Jr, Resnick LM, Laragh JH: The acute interactive effects of sodium and calcium on blood pressure. American Journal of Hypertension, 4th Scientific Meeting of the American Society of Hypertension, Vol. 2, No. 5, Part 2, pg. 120A, #1481, 1989.
109. Nicholson JP, Cigarroa J, Ward N, Marion DN, Vaughan ED Jr, Resnick LM, Laragh JH: Cellular calcium uptake mediates the pressor effects of calcium sodium volume expansion. American Journal of Hypertension, 4th Scientific Meeting of the American Society of Hypertension, Vol. 2, No. 5, Part 2, pg. 120A, #1482, 1989.
110. MK 906 Study Group: The role of a 5 alpha reductase inhibitor in benign prostatic hyperplasia. International Study Group for Steroid Hormones, Rome, 1989.
111. Sternberg CN, Yagoda A, Scher H, Watson RC, Geller N, Herr HW, Morse M, Sogani P, Vaughan ED Jr, Bander N, Fair W, Whitmore W: Patterns of response, survival and relapse in advanced urothelial cancer following M VAC therapy. Proc. Amer. Soc. Clin. Oncol., (Abstr 501):8;129, 1989.
112. Spencer JU, Sanchez RS, Vaughan ED Jr, Imperato McGinley J: The role of androgens in testicular descent in the rat. American Academy of Pediatrics, Section on Urology, Oct. 1990.
113. Imperato McGinley J, Sanchez R, Spencer J, Vaughan ED Jr: Failure of complete feminization of the external genitalia and abolition of prostate differentiation in adult male rats treated in utero with the 5 alpha-reductase inhibitor MK906 Compari-son with the antiandrogen flutamide. The Endocrine Society, #1445, p. 386, 1990.
114. Gulmi FA, Marion DN, Vaughan ED Jr: The role of atrial natriuretic peptide in the recovery of renal function after release of bilateral ureteral obstruction. Kid. Intern., 37:336, 1990.
115. Gulmi FA, Marion DN, Matthews GJ, von Lutterotti N, Vaughan ED Jr: Atrial natriuretic peptide (ANP) enhances the recov-ery of renal function and prolongs the diuresis after release of bilateral ureteral obstruction (BUO). The J. Urology/AUA 85th Annual Meeting, Vol. 143, No. 4, pp. 239A, #201, 1990.
116. Aulitzky WK, Li S, Wu D, Cheng CY, Chen Cl C, Goldstein M, Reidenberg MM, Vaughan ED Jr, Bardin CW: Monitoring of controlled nephrotoxicity with clusterin. The J. Urology/AUA 85th Annual Meeting, Vol. 143, No. 4, pp. 239A, #203, 1990.
117. Felsen D, Frye S, Seniuk S, Vaughan ED Jr: Urinary prostaglandin E2 (PGE2) and thromboxane B2 (TxB2) excretion in pa-tients with interstitial cystitis (IC). The J. Urology/AUA 85th Annual Meeting, Vol. 143, No. 4, pp. 279A, #361, 1990.
118. Byrne JC, Verhaaren M, Vaughan ED Jr: Poor isometric contraction velocity predicts TURP failure. The J. Urology/AUA 85th Annual Meeting, Vol. 143, No. 4, pp. 370A, #728, 1990.
119. von Lutterotti N, Gulmi F, Marion D, James G, Vaughan ED Jr, Laragh JH, Sealey JE: Plasma prorenin is increased after bilateral ureteral obstruction in dogs and is directly related to renal blood flow. Sixth Scientific Meeting, The American Soci-ety of Hypertension, 1991.
120. Vaughan ED Jr, Imperato-McGinley J, Cai L-Q, Orlick SD, Markisz JA, and Stein EA: Long-term treatment of patients with benign prostatic hyperplasia with 5-alpha reductase inhibitor finasteride (MK 906). J. of Endourology: 9th World Congress on Endourology and ESWL - 7th Annual Research Symposium on ESWL, 5(Suppl. 1):S87, June 19-22, 1991.
121. Imperato-McGinley J, Cai L, Orlic SD, Markisz JA, Vaughan ED Jr, and Stein EA: Long-term treatment of benign prostatic hyperplasia with 5-alpha reductase inhibitor finasteride (MK 906). 86th Annual Meeting of the A.U.A., Toronto, Ontario, Canada, June 2-6. Abst. #212, Vol. 145:265A, 1991.
122. Schlegel PN, Matthews G, Aulitzky WK, Cheng CY, Liu C, Chen CL, Saso L, Goldstein M, Janne O, Bardin CW, Vaughan ED Jr: Clusterin production in the obstructed rabbit kidney: correlations with loss of renal function. 86th Annual Meeting of the A.U.A., Toronto, Ontario, Canada, June 2-6. Abst. #462, Vol. 145:328A, 1991.
123. Jarrett TW, Vaughan ED Jr: CT scan in the diagnosis of colovesical fistula secondary to diverticulitis. 86th Annual Meeting of the A.U.A., Toronto, Ontario, Canada, June 2-6. Abst. #622, Vol. 145:368A, 1991.
124. Cerfolio RJ, Vaughan ED Jr: Idiopathic retroperitoneal fibrosis: Is there a role for post operative steroids? 86th Annual Meeting of the A.U.A., Toronto, Ontario, Canada, June 2-6. Abst. #644, Vol. 145:373A, 1991.
125. Cai L, Lesser M, Orlic SD, Markisz JA, Stein EA, Vaughan ED Jr, and Imperato-McGinley J: Relationship of prostatic spe-cific antigen and prostate size in patients before and after treatment with 5 alpha-reductase inhibitor finasteride (MK 906) for benign prostatic hypertrophy. The Endocrine Society, #1788, p. 477, 1991.
126. Blumenfeld J, Ulick S, Atlas S, Schlussel Y, Acevedo R, Muller F, Campbell W, Vaughan ED Jr, and Laragh JH: Primary aldosteronism (PA): Higher urinary 18-oxo-cortisol (OXO) and plasma ANF in adenoma (APA) than hyperplasia (AH). The American Journal of Hypertension, 7th Scientific Meeting, Vol. 5, No. 5, Part 2, p. 133A:Q29, 1992.
127. Poppas DP, Sutaria P, Sosa RE, Mininberg DT, Vaughan ED Jr: Re-establishing continuity of the ureter using laser tissue welding techniques: Evaluation of new laser tissue welding soldiers for laparoscopic surgery. J. Urol/AUA 87th Annual Meeting, Washington, D.C., May, Vol. 147, pp. 244A, Abst. #123, 1992.
128. Sosa RE, Weingram J, Stein B, Lyons JM, Poppas P, Bander NH, Vaughan ED Jr: Hypercarbia in laparoscopic pelvic lymph node dissection. J. Urol/AUA 87th Annual Meeting, Washington, D.C., May, Vol. 147, pp. 246A, Abst. #129, 1992.
129. Felsen D, Ernsberger P, Nguyen P, Sutaria P, Breslin D, Vaughan ED Jr: Imidazoline receptors: A possible site for clo-nidines action in the canine prostate. J. Urol/AUA 87th Annual Meeting, Washington, D.C., May, Vol. 147, pp. 248A, Abst. #137, 1992.
130. Jarrett TW, Gordon C, Vaughan ED Jr, Whalen GF: Effect of a fibronectin-related peptide on urothelial thermal injury. J. Urol/AUA 87th Annual Meeting, Washington, D.C., May, Vol. 147, pp. 405A, Abst. #771, 1992.
131. Spencer JR, May M, Hernandez K, Marion D, Vaughan ED Jr: The fate of long term enterocystoplasty in the rat. J. Urol/AUA 87th Annual Meeting, Washington, D.C., May, Vol. 147, pp. 430A, Abst. #869, 1992.
132. Felsen D, Frye S, Bavendam T, Trimble L, Vaughan ED Jr: Interleukin-6 activity in the urine of interstitial cystitis (IC) pa-tients. J. Urol/AUA 87th Annual Meeting, Washington, D.C., May, Vol. 147, pp. 460A, Abst. #992, 1992.
133. Alderman MH, Chang CJ, Tobin JN, Pliner V, Vaughan ED Jr, Drach G: Effect of extracorporeal shock wave lithotripsy on renal function. J. Urol/AUA 88th Annual Meeting, San Antonio, TX, May, Vol. 149, pp. 218A, Abst. #17, 1993.
134. Felsen D, Sutaria PM, Nejat RJ, Breslin D, Broder S, Vaughan ED Jr: Contraction of canine prostate by p-amino-clonidine is mediated by alpha-1 adrenergic receptors: Implications for therapy of benign prostatic hyperplasia. J. Urol/AUA 88th Annual Meeting, San Antonio, TX, May, Vol. 149, pp. 242A, Abst. #115, 1993.
135. Britanisky RG, Vaughan ED Jr: Evaluation of PSA velocity in patients with BPH. J. Urol/AUA 88th Annual Meeting, San Antonio, TX, May, Vol. 149, pp. 244A, Abst. #124, 1993.
136. Hyacinthe L, Jarrett T, Gordon C, Vaughan ED Jr, Fracchia J, Whalen G: Inhibition of gross tumors in the cauterized murine bladder with a fibronectin fragment (GRGDS). J. Urol/AUA 88th Annual Meeting, San Antonio, TX, May, Vol. 149, pp. 272A, Abst. #235, 1993.
137. Vukasin AP, Sosa RE, Vaughan ED Jr: Construction of a pyelo-ileal cutaneous anastomosis for the treatment of transitional cell tumors in a solitary kidney. J. Urol/AUA 88th Annual Meeting, San Antonio, TX, May, Vol. 149, pp. 273A, Abst. #240, 1993.
138. Abramson R, Cohen D, Herzlinger D, Vaughan ED Jr: Modification of calyceal formation by the addition of a regulatory growth factor. J. Urol/AUA 88th Annual Meeting, San Antonio, TX, May, Vol. 149, pp. 296A, Abst. #333, 1993.
139. Perlmutter AP, Miller L, Trimble LA, Marion DN, Vaughan ED Jr, Felsen D: Toradol, a non-steroidal antiinflammatory drug (NSAID) used for renal colic, decreases renal perfusion and ureteral pressure in a canine model of unilateral ureteral obstruc-tion. J. Urol/AUA 88th Annual Meeting, San Antonio, TX, May, Vol. 149, pp. 500A, Abst. #1148, 1993.
140. Felsen D, Frye S, Bavendam TG, Parsons CL, Trimble LA, Vaughan ED Jr: Urinary inflammatory mediator profiles in inter-stitial cystitis (IC) patients, patients with IC-like symptoms, and controls. J. Urol/AUA 88th Annual Meeting, San Antonio, TX, May, Vol. 149, pp. 507A, Abst. #1178, 1993.
141. Uzzo RG, Bush HL Jr, Vaughan ED Jr, and Mahler RJ: Paragangliomas presenting in the carotid body: Multifocal, hormonal and familial tendencies. A report of two cases in normotensive patients. 8th Annual Meeting, Montreal, Canada, - Eastern Vascular Society, 1994.
142. Finasteride Study Group: Four years clinical experience with finasteride in the treatment of symptomatic benign prostatic hyperplasia. XIth European Association of Urology Congress Scientific Secretariat, July 15, 1994.
143. Perlmutter AP, and Vaughan ED Jr: The creation of a volume lesion in the canine prostate using Nd:YAG laser coagulation: Concepts for clinical treatment. Oral Session 10: Benign Prostatic Hyperplasia Treatment 2. Societe Internationale D'Urolo-gie, 23rd Congress, Sydney, Australia, Sept. 18-22, 1994, p 272, #731.
144. Perlmutter AP, Lopez M, and Vaughan ED Jr: The creation of a volume lesion in the canine prostate. Nd:YAG laser coagu-lation: Concepts for clinical treatment. Lasers Surgery Medicine, Suppl. 6:61, 1994.
145. Perlmutter AP, Lopez M, and Vaughan ED Jr: The dosimetry of Nd:YAG laser coagulation in the canine prostate. J. Urol./89th Annual Meeting of the AUA, Vol. 151, No. 5, p. 331A, #415, 1994.
146. Vukasin A, Lopez M, Shichman S, Hom D, Vaughan ED Jr, Sosa RE: Oliguria in laparoscopic surgery. J. Urol./89th Annual Meeting of the AUA, Vol. 151, No. 5, p. 343A, #462, 1994.
147. Vaughan ED Jr, Vukasin A, Lopez M, Shichman S, Hom D, and Sosa RE: Renal physiologic and hormonal responses to in-creased intraabdominal pressure as utilized for laparoscopic surgery. Poster Session 34: Laparoscopy. Societe Internationale D'Urologie, 23rd Congress, Sydney, Australia, Sept. 18-22, 1994, p 288, #797.
148. Nassir Y, Regunathan S, Rookard A, Reis DJ, Vaughan ED Jr, and Felsen D: Castration of rats up-regulates the imidazoline receptor in prostate. Submitted, SBUR Meeting, 1994.
149. Muschter R, Hofstetter A, Anson K, Perlmutter AP, Vaughan ED Jr. Nd:YAG and diode lasers for interstitial laser coagula-tion of benign prostatic hyperplasia: experimental and clinical evaluation. J. Urol./90th Annual Meeting of the AUA, Vol. 153, No. 4, p. 229A, #3, 1995.
150. Felsen D, Wright EJ, McConnell F, Vaughan ED Jr: Transforming growth factor-ß (TGF-ß) and extracellular matrix (ECM) localization in rat bladder. J. Urol/90th Annual Meeting of the AUA, Vol. 153, No. 4, p. 264A, #144, 1995.
151. Poppas DP, Uzzo RG, Vargas JC, Vaughan ED Jr: Chromophore enhanced laser tissue ablation: a new model for laser prostatectomy? J. Urol/ 90th Annual Meeting of the AUA, Vol. 153, No. 4, p. 342A, #453, 1995.
152. Kessler O, Uzzo RG, Herzlinger D, Brown A, Vaughan ED Jr: Fibroblasts expressing exogenous WNT-2 support rat coagula-tion gland branching in vitro. J. Urol/90th Annual Meeting of the AUA, Vol. 153, No. 4, p. 264A, #460, 1995.
153. Wright EJ, Robertson AP, Vaughan ED Jr, Felsen D: Characterization of extracellular matrix, transforming growth factor-ß and interstitial macrophages in acute and chronic ureteral obstruction. J. Urol/90th Annual Meeting of the AUA, Vol. 153, No. 4, p. 412A, #735, 1995.
154. Wei J, Loo M, Coleman J, McGovern J, Vaughan ED Jr: Prostate cancer in Chinese American men presenting for urological evaluation. J. Urol/90th Annual Meeting of the AUA, Vol. 153, No. 4, p. 417A, #754, 1995.
155. Vargas JC, Fields D, Razvi H, Vaughan ED Jr, Sosa RE: Direct renal parenchyal compression to 15 mmHg produces olig-uria. J. Urol/90th Annual Meeting of the AUA, Vol. 153, No. 4, p. 514A, #1142, 1995.
156. Schulsinger DA, Felsen D, Marion DN and Vaughan ED Jr: Expression, localization and inhibition of inducible nitric oxide synthase (iNOS) following unilateral ureteral obstruction (UUO) in rat kidney. Surgical Forum, 1996.
157. Lemack GE, Vaughan ED Jr, Felsen D, Szabo Z, Boyd CD: Expression of rat tropoelastin in transgenic mouse bladder: physiologic and histologic effects. AUA, Vol. 155, No. 5, p. 599A, #1151, 1996.
158. Uzzo RG, Qiao J, Herzlinger D, Vaughan ED Jr: Fibroblastic growth factor-7 (FGF-7) initiates ureteral budding and growth in vitro. AUA, Vol. 155, No. 5, p. 471A, #643, 1996.
159. Uzzo RG, Herzlinger D, Vaughan ED Jr: WNT Proto-oncogenes and the growth of high grade androgen resistant prostatic epithelia. AUA, Vol. 155, No. 5, p. 509A, #793, 1996.
160. Vaughan ED Jr, Tobin JN, Alderman MH, Sosa RE, Drach GW, and the NEMA Kidney Stone Blood Pressure Study Group (KSBPS): Extracorporeal shock wave monotherapy does not cause renal dysfunction or elevated blood pressure. AUA, Vol. 155, No. 5, p. 539A, #915, 1996.
161. Sutaria PM, Ohebshalom M, Vaughan ED Jr, McCaffrey TA, Felsen D: Expression of transforming growth factor beta (TGF-) receptor types I and II in normal kidney and after chronic unilateral ureteral obstruction (UUO). AUA, Vol. 155, No. 5, p. 561A, #1002, 1996.
162. Schulsinger DA, Felsen D, Gulmi FA, Gross S, Vaughan ED Jr: The expression and localization of inducible nitric oxide syn-thase (iNOS) following unilateral ureteral obstruction (UUO) in rat kidney. AUA, Vol. 155, No. 5, p. 561A, #1003, 1996.
163. Schulsinger DA, Felsen D, Marion DN and Vaughan ED Jr: Activation of the nitric oxide system following late unilateral ureteral obstruction (UUO). J. Urol/Annual Meeting of the AUA, 1997.
164. Kohan AD, Danziger M and Vaughan ED Jr: Extracellular matrix (ECM) and cystometric changes in the bladder of rats with bladder outlet obstruction (BOO): Effects of aging. J. Urol/Annual Meeting of the AUA, Vol 157, No. 4, p. 173, #669, 1997.
165. Ostad M, OConnor LT, Vaughan ED Jr, Gross SS and Felsen D: Inducible nitric oxide synthase (iNOS) is expressed in nor-mal and obstructed rat bladder. J. Urol/Annual Meeting of the AUA, Vol 157, No. 4, p. 173, #670, 1997.
166. Schulsinger DA, Marion D, Kim F, Felsen D, Cartelli C, Gross S and Vaughan ED Jr: The nitric oxide (NO) system is acti-vated during late unilateral ureteral obstruction (UUO). J. Urol/Annual Meeting of the AUA, Vol 157, No. 4, p. 209, #815, 1997.
167. Kim FY, Cartelli C, Hanauske-Abel HM, Vaughan ED Jr, and Felsen D: Steroids ameliorate renal interstitial fibrosis in rats with chronic unilateral ureteral obstruction (UUO). J. Urol/Annual Meeting of the AUA, Vol 157, No. 4, p. 209, #816, 1997.
168. Gardner TA, Lemer ML, Schlegel PN, Waldbaum R, Vaughan ED Jr and Steckel J: Microfocal prostate cancer: Biopsy can-cer volume does not predict actual tumor volume. J. Urol/Annual Meeting of the AUA, Vol 157, No. 4, p. 295, #1148, 1997.
169. Schulsinger DA, Perlmutter AP, Sosa RE, Marion D, Vaughan ED Jr: The effect of cryoablation on adrenal parenchymal and adrenal vascular temperature. J Endourology, 12:S1 88,1998.
170. Schulsinger DA, Perlmutter AP, Sosa RE, Marion D, Vaughan ED Jr: The effect of renal cryoablation on the renal paren-chyma and renal vascular temperature. J Urol, 159:S152, 1998.
171. Schulsinger DA, Perlmutter AP, Sosa RE, Marion D, Vaughan ED Jr: The effect of cryoablation on adrenal parenchymal and adrenal vascular temperature. J of Endourology 12:S88, 1998.
172. Schulsinger DA, Perlmutter AP, Sosa RE, Marion D, Esser R, Muschter R, Sroka R, Vaughan ED Jr: Histological evaluation following acute laparoscopic interstitial Ho:YAG laser irradiation of the adrenal in the canine model. J of Endourolgy 12:S90, 1998.
173. Schulsinger DA, Perlmutter A, Sosa RE, Marion D, Ravizzini P, Guarnizo E, Muschter R, Sroka R, Vaughan ED Jr: Laparo-scopic Ho:YAG laser kidney irradiation: Feasibility study in the canine model. J Endourolgy, 12:S90, 1998.
174. Choi B, Maluccio M, Rao J, Sharma VK, Li B, Ding R, Lagman M, Sadelain M, Vaughan ED Jr, Suthanthiran M: Inter-leukin-2 gene therapy for renal cell cancer. American Society of Nephrology, 31st Annual Meeting, October 25-28,Vol 9, 436A, 1998.
175. Felsen D, Vaughan ED Jr, Lemer ML: Inhibition of inducible nitric oxide synthase (iNOS) differentially affects bladder func-tion in normal rats and in rats with partial bladder outlet obstruction (BOO): An in vivo cystometric evaluation. J. Urol/Annual Meeting of the AUA, Vol 159, No. 5, p. 18, #70, 1998.
176. Hochberg DA, Chen J, Vaughan ED Jr, Felsen D: Interstitial fibrosis is exacerbated in unilateral ureteral obstruction (UUO) in mice lacking the gene for inducible nitric oxide synthase (iNOS). J. Urol/Annual Meeting of the AUA, Vol 159, No. 5, p. 68, #257, 1998.
177. Vaughan ED Jr, Cox DS: Chronic administration of dehydroepiandrosterone (DHEA) does not increase serum testosterone or prostatic specific antigen (PSA) in normal men. J. Urol/Annual Meeting of the AUA, Vol 159, No. 5, p. 74, #278, 1998.
178. Perlmutter A, Schulsinger DA, Sosa RE, Marion D, Vaughan ED Jr: The effect of renal cryoablation on the renal paren-chyma and renal vasculature temperature. J. Urol/Annual Meeting of the AUA, Vol 159, No. 5, p. 152, #577, 1998.
179. Schulsinger DA, Perlmutter AP, Sosa RE, Marion D and Vaughan ED, Jr. The effect of cryoablation on adrenal parenchymal and adrenal vascular temperature. J of Endourology 12:S88, 1998.
180. Schulsinger DA, Perlmutter A, Sosa RE, Marion D, Esser R, Muschter R, Sroka T, Vaughan ED, Jr. Histological evaluation following acute laparoscopic interstitial Ho:YAG laser irradiation of the adrenal in the canine model. J of Endourology 12:S90, 1998.
181. Schulsinger DA, Perlmutter A, Sosa RE, Marion D, Ravizzini P, Guarnizo E, Muschter T, Sroka R, Vaughan ED, Jr. Laparo-scopic HO:YAG laser kidney irradiation: Feasibility study in the canine model. J of Endourology 12:S90, 1998.
182. Schulsinger DA, Sosa RE, Perlmutter AP, Ravizzini PI, Guarnizo E, Marion D, Nguyen HP, Vaughan ED, Jr. Biochemical and histological evaluation of the kidney following chronic laparoscopic interstitial renal cryoablation in the canine model.
183. Schulsinger DA, Perlmutter AP, Sosa RE, Marion D, Guarnizo E, Ravizzini PI, Muschter R, Vaughan ED, Jr. Histological evaluation following acute laparoscopic interstitial Homium: YAG (Ho: YAG) laser irradiation on renal and adrenal tissues in the canine model (Society for Urology and Engineering, Inc.,1999).
184. Schichman SJ, Sosa RE, Herndon CDA, Seiba M, Vaughan ED. Lateral transperitoneal laparoscopic adrenalectomy: a safe and versaltile laparoscopic technique. J. Urol/Annual Meeting of the AUA, Vol. 161, No. 4 Supp. p. 21, #68, 1999.
185. Schulsinger DA, Sosa RE, Perlmutter AP, Guarnizo E, Ravizzini PI, Marion D, Nguyen HP, Vaughan ED Jr. Histological evaluation following chronic laparoscopic adrenal cryoablation. J. Urol/Annual Meeting of the AUA, Vol. 161, No. 4 Supp. p. 22, #71, 1999.
186. Miyajima A, Chen J, Kirman I, Poppas DP, Vaughan ED Jr., Felsen D. Mechanical stretch induces nitric oxide sythase in rat renal epithelial cells. J. Urol/Annual Meeting of the AUA, Vol. 161, No. 4 Supp. p. 81, #310 1999.
187. Miyajima A, Chen J, Kirman I, Poppas DP, Vaughan ED Jr, Felsen D. Interaction of transforming growth facto-beta and ni-tric oxide in rat renal epithelial cells exposed to angiotensin II. J. Urol/Annual Meeting of the AUA, Vol. 161, No. 4 Supp. p.82, #311, 1999.
188. Schulsinger DA, Vaughan ED JR, Herzlinger D. FGF - 7 is essential for formation of the urinary transitional epithelium. J. Urol/Annual Meeting of the AUA, Vol. 161, No. 4 Supp. p. 112, #423, 1999.
189. Choi BB, Maluccio M, Sadelain M, Vaughan ED, Suthanthiran M. Development of a novel retroviral vector based IL2 gene therapy: demonstration of efficacy in a renal cell carcinoma model. J. Urol/Annual Meeting of the AUA, Vol. 161, No. 4 Supp. p. 138, #125, 1999.
190. Scherr DS, Vaughan ED Jr., Wei J, Chung M, Felsen D, Knudsen BS. BCL - 2 and P53 expression in clinically localized prostate cancer predicts the response of patients to external beam radiotherapy. J. Urol/Annual Meeting of the AUA, Vol. 161, No. 4 Supp. p. 156 #598, 1999.
191. Pavlovich CP, Vaughan ED Jr. A stage specific surveillance protocol for patients after nephroureterectomy for upper tract transitional cell carcinoma (TCC): A multiinstitutional analysis. J. Urol/Annual Meeting of the AUA, Vol. 161, No. 4 Supp. p. 196, #747, 1999.
192. Lemack GE, Szabo Z, Urban Z, Boyd CD, Csiszar K, Vaughan ED Jr, Felsen D. Altered bladder funcion in transgenic mice expressing rat elastin. Neurourology and Urodynamics 18:55-68, 1999.
193. Guarnizo E, Pavlovich CP, Seiba M, Carlson DL, Vaughan ED Jr, Sosa RE. Ureteroscopic biopsy of upper tract urothelial carcinoma: Improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. The J.of Urology, vol. 163, 52-55, 2000.
194. Miyajima A, Chen J, Poppas DP, Vaughan, ED Jr., Felsen D, Role of nitric oxide in renal tubular apoptosis of unilateral uret-eral obstruction. J. Urol/Annual Meeting of the AUA, Vol. 163, No. 4 Supp. p. 83 #365, 2000.
195. Stern J, Miyajima A, Chen J, Poppas DP, Vaughan ED, Jr., Felsen D. Transforming growth factor- [TGF-] mediated ex-pression of P53 and BCL-2 in unilateral ureteral obstruction. J. Urol/Annual Meeting of the AUA, Vol. 163, No. 4 Supp. p. 84 #368, 2000.
196. Miyajima A, Chen J, Stern J, Poppas DP, Vaughan ED, Jr., Felsen D. Antibodies to transforming growth factor- [TGF-] decreases renal tubular apoptosis in unilateral ureteral obstruction. J. Urol/Annual Meeting of the AUA, Vol. 163, No. 4 Supp. p. 84 #369, 2000.
197. Scherr DS, Vaughan ED, Jr., Pavlovich CP, Pitts WR, Jr., Knudsen B. Collagen type I crosslinked N-telopeptide (NTX) as a urinary marker for osteoporosis in localized prostate cancer patients and the role of diethylstilbesterol. J. Urol/Annual Meet-ing of the AUA, Vol. 163, No. 4 Supp. p. 259 #1151, 2000
198. Dasari N, Nori D, Vaughan ED Jr., Parikh S, Shemtov M, Allbright RM, Poli JMR, Pressor J, Osian A. Role of combined external beam radiatioin therapy and outpatient conformal brachytherapy for clinically localized prostate cancer. Submitted American Brachytherapy Society meeting, 2001
199. Felsen D, Seshan SV, Chen J, Hyman MJ, Vaughan ED Jr., Ledbetter S., Poppas DP. Role of transforming growth factor- in renal cellular changes following reversal of unilateral obstruction (UUO) in rats. Supplement to ASN/ISN World Congress of Nephrology, 2001.
200. Tash J, David S, Sun TT, Vaughan ED Jr., Herzlinger D, Fuchs E, Degenstein L. FGF-7 regulates the formalin of the inter-mediate layers of the bladder urothelium. J Urol/Annual Meeting of the AUA, Vol.165, No.5 p.34 #141, 2001.
201. Hyman M, Chen J, Seshan SV, Poppas DP,Vaughan ED Jr., Felsen D. Changes in interstitial renal fibrosis and renal function following surgical reversal of unilateral ureteral obstruction. J Urol/Annual Meeting of the AUA, Vol. 165, No.5 p. 94 #384,2001.
202. Smith EB, Vaughan ED Jr., Bloom DA. Edward Lawrence Keyes: A major name in genitourinary surgery. J Urol/Annual Meeting of the AUA, Vol. 165, No. 5 p. 179 #741, 2001.
203. Dasari N, Nori D, Vaughan ED Jr., Parikh S., Shemtov M, Poli JMR, Allbright RM. Percent positive biopsies and biochemi-cal outcome after combined external beam radiation therapy and out-patient conformal brachytherapy for clinically localized prostate cancer. American Society of Therapeutic Radiation Oncology, 2002.
204. Nelson K, Tash JA, David SG, Schlegel PN, Vaughan ED Jr., Herzlinger DA. FGF-7 Null mice exhibit impaired bladder urothelial repair. J Urol, Vol. 167, No.4 p.36, #144, 2002.
205. Walmsley K, Seshun SV, Chen J, Ledbetter S, Vaughan ED Jr., Poppas DP, Felsen D. Effects of antibody to transforming growth factor-B in unilateral ureteral obstruction (UUO) of mice lacking the gene for inducible nitric oxide synthase (INOS). J Urol, Vol. 167, No.4, p.93, #374, 2002.
206. Felsen D, Hyman MJ, Seshan SV, Chen J, Ledbetter S, Vaughan ED Jr., Poppas DP. Antibody to transforming growth factor-B (TGF-B) ameliorates renal histopathological changes which occur following reversal of unilateral ureteral obstruction (UUO) in rats. J Urol, Vol. 167, No. 4, p. 94, #375, 2002.
207. Ito K, Chen J, Poppas DP, Vaughan ED Jr., Felsen D. Dietary L-Arginine supplementation improves both glomerular filtra-tion rate (GFR) and renal blood flow (RBF) after 24 hours of unilateral ureteral obstruction (UUO) in rats. J Urol, Vol. 167, No. 4, p.95, #379, 2002.
208. Stern JM, Chen J, Silver RB, Poppas DP, Vaughan ED Jr., Felsen D. An association between unilateral ureteral obstruction and dopamine 1A receptor expression reveals novel effects of dopamine on transforming growth factor-B and nitric oxide re-lease in renal proximal tubule cells. Submitted, 2002.
209. Vaughan ED Jr. Cyclo-oxygenase 2 is over-expressed in RCC compared with normal kidney. Presented 2002 BAUS. Submit-ted Urology Times.
210. Kellner D, Chen J, Seshan SV, Poppas DP, Vaughan ED Jr., Felsen D. Losartan, an angiotensin II (AII) receptor antagonist, decreases apoptosis and macrophage infiltration in unilateral ureteral obstruction (UUO) in rats. J Urol, Vol. 169, No. 4, p. 9, #33, 2003.
211. Stern J, Chen J, Silver R, Poppas DP, Vaughan ED Jr., Felsen D. Effect of UUO on dopamine 1A receptor (D1AR) expres-sion reveals a link between dopamine transforming growth factor-B and nitric oxide. J Urol, Vol. 169, No.4, p.111, #431, 2003.
212. Ito K, Chen J, El Chaar MM, Stern JM, Seshan SV, Khodadadian J, Eaton C, Poppas DP, Vaughan ED Jr., Felsen D. Dietary L-Arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction (UUO) in rats. J Urol, Vol. 169, No.4, p.111, #432, 2003.
213. Ito K, Chen J, El Chaar MM, Stern JM, Seshan SV, Khodadadian J, Poppas DP, Vaughan ED Jr., Felsen D. Renal damage progresse猀 搀攀猀瀀椀琀攀 椀洀瀀爀漀瘀攀洀攀渀琀 漀昀 爀攀渀愀氀 昀甀渀挀琀椀漀渀 愀昀琀攀爀 爀攀氀椀攀昀 漀昀 甀渀椀氀愀琀攀爀愀氀 甀爀攀琀攀爀愀氀 漀戀猀琀爀甀挀琀椀漀渀 ⠀唀唀伀⤀ 椀渀 愀搀甀氀琀 爀愀琀猀⸀ 䨀 唀爀漀氀Ⰰ 嘀漀氀⸀ 㘀㤀Ⰰ 一漀⸀㐀Ⰰ 瀀⸀㈀Ⰰ ⌀㐀㌀㌀Ⰰ ㈀ ㌀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㈀㐀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀䔀氀 䌀栀愀愀爀 䴀䴀Ⰰ 䌀栀攀渀 䨀Ⰰ 䄀琀琀椀愀 䔀Ⰰ 䠀愀渀渀愀昀椀渀 䨀Ⰰ 倀漀瀀瀀愀猀 䐀倀Ⰰ 嘀愀甀最栀愀渀 䔀搀 䨀爀⸀Ⰰ 䘀攀氀猀攀渀 䐀⸀ 䔀昀昀攀挀琀 漀昀 猀攀氀攀挀琀椀瘀攀 挀礀挀氀漀漀砀礀最攀渀愀猀攀ⴀ㈀ ⠀䌀伀堀ⴀ㈀⤀ 椀渀栀椀戀椀琀漀爀 漀渀 攀砀琀爀愀挀攀氀氀甀氀愀爀 洀愀琀爀椀砀 ⠀䔀䌀䴀⤀ 愀渀搀 琀爀愀渀猀昀漀爀洀椀渀最 最爀漀眀琀栀 昀愀挀琀漀爀ⴀ䈀 ⠀吀䜀䘀ⴀ䈀⤀ 攀砀瀀爀攀猀猀椀漀渀 椀渀 猀琀爀攀琀挀栀攀搀 爀攀渀愀氀 昀椀ⴀ戀爀漀戀氀愀猀琀猀⸀ 䨀 唀爀漀氀Ⰰ 嘀漀氀⸀ 㘀㤀Ⰰ 一漀⸀㐀Ⰰ 瀀⸀㌀Ⰰ ⌀㐀㌀㤀Ⰰ ㈀ ㌀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㈀㔀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀䤀琀漀 䬀Ⰰ 䌀栀攀渀 䨀Ⰰ 匀攀猀栀愀渀 匀嘀Ⰰ 䬀栀漀搀愀搀愀搀椀愀渀 䨀Ⰰ 娀栀愀漀 堀Ⰰ 䔀愀琀漀渀 䌀Ⰰ 倀漀瀀瀀愀猀 䐀倀Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀⸀Ⰰ 䰀椀瀀欀漀眀椀琀稀 䴀Ⰰ 䘀攀氀猀攀渀 䐀⸀ 䰀椀瀀漀猀漀洀攀ⴀ洀攀搀椀愀琀攀搀 琀爀愀渀猀昀攀爀 漀昀 椀渀搀甀挀椀戀氀攀 渀椀琀爀椀挀 漀砀椀搀攀 猀礀渀琀栀愀猀攀 最攀渀攀 椀渀琀漀 琀栀攀 欀椀搀渀攀礀⸀ 䨀 唀爀漀氀Ⰰ 嘀漀氀⸀ 㘀㤀Ⰰ 一漀⸀㐀Ⰰ 瀀⸀㐀Ⰰ ⌀㐀㐀㈀Ⰰ ㈀ ㌀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㈀㘀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀䐀愀瘀椀搀 匀Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀⸀Ⰰ 䠀攀爀稀氀椀渀最攀爀 䐀⸀ 䐀攀瘀攀氀漀瀀洀攀渀琀 漀昀 琀栀攀 甀爀攀琀攀爀 愀渀搀 瀀攀氀瘀椀猀⸀ 䨀 唀爀漀氀Ⰰ 嘀漀氀⸀ 㘀㤀Ⰰ 一漀⸀㐀Ⰰ 瀀⸀㘀㠀Ⰰ ⌀㘀㐀㠀Ⰰ ㈀ ㌀⸀㰀戀爀⼀㸀㰀戀爀⼀㸀㈀㜀⸀☀渀戀猀瀀㬀☀渀戀猀; El Chaar MM, Chen J, Stern J, Poppas DP, Vaughan Ed Jr., Ito K, Ledbetter S, Felsen D. Effects of antibody to transforming growth factor-B (TGF-B) and enalapril in unilateral ureteral obstruction (UUO). J Urol, Vol. 169, No.4, p.168, #649, 2003.
Publications Cont'd.: Book Chapters
1. Laragh JH, Baer L, Brunner HR, Buhler FR, Sealey JE, and Vaughan ED Jr: The renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease (revised), In: Hypertension Manual, JH Laragh (ed.). Yorke Pub. Co.: New York, 1974 (pp. 313-351).
2. Sealey JE, Buhler FR, Laragh JH, and Vaughan ED Jr: The physiology of renin secretion in essential hypertension: Estima-tion of renin secretion rate and plasma flow from peripheral and renal vein renin levels, In: Hypertension Manual, JH Laragh (ed.). Yorke Pub. Co.:New York, 1974 (pp. 537-558).
3. Vaughan ED Jr, Buhler FR, Laragh JH, Sealey JE, Baer L, and Bard RH: Renovascular hypertension: Renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability, In: Hy-pertension Manual, JH Laragh (ed.). Yorke Pub. Co.:New York, 1974 (pp. 559-584).
4. Vaughan ED Jr, Laragh JH, Gavras I, Buhler FR, Gavras H, Brunner HR, and Baer L: The volume factor in low and normal renin essential hypertension: Its treatment with either spirolactone or chlorthalidone, In: Hypertension Manual, JH Laragh (ed.). Yorke Pub. Co.:New York, 1974 (pp. 851-872).
5. Buhler FR, Laragh JH, Vaughan ED Jr, Brunner HR, Gavras H, and Baer L: The antihypertensive action of propranolol: Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension, In: Hypertension Manual, JH Laragh (ed.). Yorke Pub. Co.:New York, 1974 (pp. 873-898).
6. Vaughan ED Jr, and Wyker AW Jr: Obstructive uropathy, Chapter 4, In: Method of Urology, AW Wyker Jr, JY Gillenwater (eds.). Williams & Wilkins Co.:Baltimore, 1975, (pp. 59-60).
7. Vaughan ED Jr, and Middleton GW: Embryology and congenital anomalies, Chapter 7, In: Method of Urology, AW Wyker Jr, JY Gillenwater (eds.). Williams & Wilkins Co.:Baltimore, 1975, (pp. 87-103).
8. Vaughan ED Jr: Endocrine function of the kidney, Chapter 11, In: Method of Urology, AW Wyker Jr, JY Gillenwater (eds.). Williams & Wilkins Co.:Baltimore, 1975, (pp. 164-171).
9. Vaughan ED Jr: Disorders of the ureter, Chapter 13, In: Method of Urology, AW Wyker Jr, JY Gillenwater (eds.). Williams & Wilkins Co.:Baltimore, 1975, (pp. 183-189).
10. Vaughan ED Jr: Pathophysiology of renovascular hypertension, In: Vascular Surgery, RB Rutherford (ed.). W.B. Saunders Co.:Philadelphia, 1977, (pp. 979-991).
11. Vaughan ED Jr: The renin-angiotensin-aldosterone system in renal and adrenal hypertension, In: Urology in Practice, CJ De-vine Jr, JF Stecker (eds.). Little Brown & Co.:Boston, 1978, (pp. 831-852).
12. Bueschen AJ, and Vaughan ED Jr: Radionuclide scanning of the genitourinary tract, In: Urology in Practice, CJ Devine Jr, JF Stecker (eds.). Little Brown & Co.:Boston, 1978, (pp. 123-132).
13. Vaughan ED Jr: Hypertension secondary to renoparenchymal disease, In: Current Urologic Therapy, JJ Kaufman (ed.), 1980, (pp. 161-162).
14. Laragh JH, Sealey JE, Vaughan ED Jr, Baer L, Buhler FR, Brunner HR, and Gavras H: The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension, Chapter 14, In: Topics in Hypertension, JH Laragh (ed.). Yorke Medical Books: New York, 1980.
15. Vaughan ED Jr, Sos TA, Sniderman KW, Pickering TG, Case DB, Sealey JE, and Laragh JH: Renal venous renin secretory patterns before and after percutaneous transluminal angioplasty in patients with renovascular hypertension: Verification of analytic criteria, In: Frontiers in Hypertension Research, JH Laragh, FR Buhler, and DW Seldin (eds.). Springer-Verlag:New York, 1981, (pp. 173-177).
16. Vaughan ED Jr: Renal artery stenosis, Chapter 10, In: Contemporary Issues in Nephrology, BM Brenner and JH Stein (eds.). Churchill Livingston, 1981, (Vol. 8, pp. 247-269)
17. Laragh JH, Sealey JE, Vaughan ED Jr, Pickering TG, Case DB, Sos TA, and Sniderman KW: Renal venous renin secretory patterns before and after percutaneous transluminal angioplasty: Verification of mathematical diagnostic criteria, In: Proceed-ings 8th Int. Congress of Nephrology. S. Karger Basel, 1981, (pp. 457).
18. Vaughan ED Jr: Renovascular hypertension and coarctation of the aorta, Chapter 4, In: Clinical Hypertension and Hypoten-sion, H Gavras and HR Brunner (eds.). Marcel Dekker:New York, 1982.
19. Sos TA, Sniderman KW, Pickering TG, Vaughan ED Jr, Case DB, and Laragh JH: Percutaneous transluminal renal angio-plasty: Experience in over 100 arteries, In: Transluminal Coronary Angioplasty and Intracoronary Thrombolysis, Kaltenbach (ed.). Springer-Verlag:Berlin Heidelberg, 1982.
20. Riehle RA Jr, and Vaughan ED Jr: The kidney and genito-urinary system, In: Yearbook of Health and Medicine, Collier's Encyclopedia. MacMillan Publishing Co.:New York, 1982.
21. Sos TA, Vaughan ED Jr, Pickering TG, Case DB, Sniderman KW, Sealey JE, and Laragh JH: Diagnosis of renovascular hy-pertension and evaluation of "surgical" curability, Chapter 9, In: Transluminal Angioplasty, WR Castaneda-Zuniga (ed.). Thieme-Stratton, Inc.:New York, 1983, (pp. 57-61).
22. Vaughan ED Jr: Overview: Chapters on open prostatectomy, In: Current Operative Urology, ED Whitehead and E Leiter (eds.). Harper & Row: Haganstown, Maryland, 1984.
23. Vaughan ED Jr: Peripheral and renal vein renin activity in renovascular hypertension, Chapter 9, In: Renovascular Hyperten-sion, JC Stanley, CB Ernst, and WJ Fry (eds.)., 1984, (pp. 146-156).
24. Vaughan ED Jr: Pathophysiology of renovascular hypertension, Chapter 108, In: Vascular Surgery, 2nd Edition. RB Ruther-ford (ed.). W.B. Saunders Co.:Philadelphia, 1984, (pp. 1109-1121).
25. Bolton WK and Vaughan ED Jr: A comparative study of open surgical and percutaneous renal biopsies, Chapter 23, In: Cur-rent Operative Urology, 2nd Edition. Harper & Row, 1984, (pp. 293-297).
26. Sosa RE and Vaughan ED Jr: Renovascular hypertension, Chapter 34, In: General Urology, 11th Edition. DR Smith (ed.). Lange Medical Publications:Los Altos, California, 1984, (pp. 598-607).
27. Riehle RA Jr and Vaughan ED Jr: Disease of the bladder in the elderly, Chapter 8, In: Urology in the Elderly, JC Brockle-hurst (ed.). Churchill Livingston:London, 1984.
28. Vaughan ED Jr: Primary reninoma of the kidney, In: Current Urologic Therapy, JJ Kaufman (ed.), 1985, (pp. 102-103).
29. Vaughan ED Jr, Case DB, Pickering TG, Sosa RE, Sos TA, and Laragh JH: Indication for intervention in patients with reno-vascular hypertension, In: Hypertension and the Kidney, JG Porush (ed.). Grune & Stratton, Inc., 1985, (pp. A136-A144).
30. Vaughan ED Jr, Case DB, Pickering TG, Sosa RE, Sos TA, and Laragh JH: Renovascular hypertension, Chapter 5, In: Cur-rent Trends in Urology, MI Resnick (ed.). Williams & Wilkins, 1985, (Vol. 3, pp. 69).
31. Sosa RE, Volpe M, Vaughan ED Jr, and Maack T: Renal hemodynamic effects of atrial natriuretic factor, Chapter 14, In: Surgical Forum, TR Bezin (ed.), 1985, (Vol. 36, pp. 633-635).
32. Leslie BR and Vaughan ED Jr: Normal renal physiology, Chapter 2, In: Campbell's Urology, 5th Edition, 1986, (pp. 75-93).
33. Vaughan ED Jr: Renovascular hypertension, Chapter 58, In: Campbell's Urology, 5th Edition, 1986, (pp. 2298-2325).
34. Marshall VF, Vaughan ED Jr, and Parnell JP: Suprapubic vesicourethral suspension (Marshall-Marchetti-Krantz) for stress incontinence, Chapter 73, In: Campbell's Urology, 5th Edition, 1986, (pp. 2711-2717).
35. Riehle RA Jr, and Vaughan ED Jr: Specialized surgical approaches to the kidney, In: Operative Surgery, 4th Edition. H Dudley, and D Carter (eds.), 1986, (pp. 33-47).
36. Felsen D, and Vaughan ED Jr: Endocrine function of the renal parenchyma, Chapter 5, In: Urologic Endocrinology, J Rajfer (ed.). W.B. Saunders Co., 1986, (pp. 112-138).
37. Vaughan ED Jr: Renal hypertension, Chapter 5, In: Urologic Endocrin-ology, J Rajfer (ed.). W.B. Saunders Co., 1986, (pp. 138-153).
38. Vaughan ED Jr, Pickering TG, Case DB, Sos TA, and Laragh JH: Hypertension in renovascular disease, In: Hypertension in Kidney Disease, JS Cheigh, AL Rubin and KH Stenzel (eds.). Martinus Nijhoff, 1986, (pp. 77-98).
39. Sosa RE, and Vaughan ED Jr: Hypertension in urological disease, In: Hypertension in Kidney Disease, JS Cheigh, AL Rubin and KH Stenzel (eds.). Martinus Nijhoff, 1986, (pp. 99-113).
40. Sosa RE, and Vaughan ED Jr: Renovascular hypertension, Chapter 25, In: Adult and Pediatric Urology, JY Gillenwater, JT Grayhack, SS Howards, and JW Duckett (eds.). Year Book Med. Publish., 1987, (pp. 752-776).
41. Sosa RE, and Vaughan ED Jr: Retroperitoneal fibrosis of known etiology, In: Current Therapy in Genitourinary Surgery, MI Resnick and ED Kursh (eds.). B.C. Decker, 1987, (pp. 332).
42. Sosa RE, and Vaughan ED Jr: Hypertension in unilateral renal parenchymal disease, In: Current Therapy in Genitourinary Surgery, MI Resnick and ED Kursh (eds.). B.C. Decker, 1987, (pp. 431).
43. Vaughan ED Jr, Pickering TG, and Laragh JH: Identifying patients with renovascular hypertension, Chapter 42, In: The Kidney in Hypertension, NM Kaplan, BM Brenner, and JH Laragh (eds.). Raven Press, 1987, (pp. 91-108).
44. Vaughan ED Jr: Pathophysiology of renovascular hypertension, Chapter 109, In: Vascular Surgery, 3rd Edition. RB Ruther-ford (ed.). W.B. Saunders Co.:Philadelphia, 1988, (pp. 2065).
45. Moore M, Amberson JB, Kazam E, and Vaughan ED Jr: Anatomy, histology, embryology, Chapter 1, In: Adrenal Disorders, ED Vaughan Jr, and RM Carey (eds.). Thieme Medical Publishers, Inc.:New York, 1989, (pp. 1-11).
46. Siragy HM, Vaughan ED Jr, and Carey RM: Cushing's syndrome, Chapter 5, In: Adrenal Disorders, ED Vaughan Jr, and RM Carey (eds.). Thieme Medical Publishers, Inc.:New York, 1989, (pp. 147-169).
47. May ME, Vaughan ED Jr, and Carey RM: Adrenocortical insufficiency - clinical aspects, Chapter 6, In: Adrenal Disorders, ED Vaughan Jr, and RM Carey (eds.). Thieme Medical Publishers, Inc.:New York, 1989, (pp. 171-189).
48. Vaughan ED Jr, and Carey RM: Adrenal carcinoma, Chapter 9, In: Adrenal Disorders, ED Vaughan Jr, and RM Carey (eds.). Thieme Medical Publishers, Inc.:New York, 1989, (pp. 231-242).
49. Vaughan ED Jr, Atlas S, and Carey RM: Hyperaldosteronism, Chapter 10, In: Adrenal Disorders, ED Vaughan Jr, and RM Carey (eds.). Thieme Medical Publishers, Inc.:New York, 1989, (pp. 243-258).
50. Reckler JM, Vaughan ED Jr, Tjeuw M, and Carey RM: Pheochromocytoma, Chapter 11, In: Adrenal Disorders, ED Vaughan Jr, and RM Carey (eds.). Thieme Medical Publishers, Inc.:New York, 1989, (pp. 259-273).
51. Gilbert BR, and Vaughan ED Jr: Evaluation of renal function, Chapter 9, In: Diagnostic Techniques in Urology, O'Reilly, George & Weiss (eds.). W.B. Saunders Co., 1989.
52. Vaughan ED Jr: Pathophysiology of renovascular hypertension, In: Vascular Surgery, 3rd Edition. RB Rutherford (ed.). W.B. Saunders Co., Vol. I., 1989.
53. Yagoda A, Scher HI, Herr HW, Sternberg CN, Reuter V, Dershaw DD, Bosl GJ, Morse MJ, Sogani PC, Watson RC, Geller N, Vaughan ED Jr, Whitmore WF Jr, and Fair WR: Phase I/II trial of M-Vac for primary urothelial tract tumors, In: Sys-temic Therapy for Genitourinary Cancer, DC Johnson, CJ Logothetis, and AC vonEschenbach (eds.). Yearbook Medical Publishers Co.:Chicago, 1989, (pp. 85-93).
54. Vaughan ED Jr (Comments), In: Atlas of Urologic Surgery, F Hinman Jr (ed.). W.B. Saunders: Philadelphia, 1989, (p. 415 and 927).
55. Volpe, M., Sosa, R.E., Atlas, S.A., Camargo, M.J., Sala, C., Muller, F.B., Vaughan, E.D., Jr. and Laragh, J.H.: Atrial natri-uretic factor attenuates hypertension induced by acute unilateral renal artery clipping in rats, In: American Society of Hyper-tension Symposium Series. Progress in Atrial Peptide Research, Vol. 3. BM Brenner, JH Laragh (eds.). Raven Press: New York, 1989 (pp. 561-564).
56. Vaughan ED Jr, and Sosa RE: Hypertension and hydronephrosis, In: Hypertension: Pathophysiology, Diagnosis and Man-agement, JH Laragh, and BM Brenner (eds.). Raven Press:New York, Vol. 2, 1990.
57. Gilbert BR, and Vaughan ED Jr: Pathophysiology of the aging kidney, In: Clinics in Geriatric Medicine; Urologic Care in the Elderly, GH Badlani, and AD Smith (eds.), 1990, (Vol. 6, No. 1, pp. 13).
58. Sosa RE, and Vaughan ED Jr: Renal hypertension, In: Scientific Foundations of Urology, 3rd Edition. GD Chisholm, and WR Fair (eds.). Heinemann Medical Books:Oxford and Year Book Medical Publishers, Inc.:Chicago, 1990.
59. Vaughan ED Jr: Adrenal surgery, Chapter 1, In: Operative Urology, FF Marshall (ed.). W.B. Saunders Co.:Philadelphia, 1991.
60. Sosa RE, and Vaughan ED Jr: Renovascular hypertension, In: General Urology, 12th Edition. DR Smith (ed.). Lange Medical Publications:Los Altos, CA, 1991.
61. Vaughan ED Jr: Overview - specialized methodologies, In: Genitourinary Surgery, MJ Droller (ed.), 1991.
62. Vaughan ED Jr: Special comment on Adrenalectomy Chapter, In: Mastery of Surgery: Urologic Surgery, JE Fowler Jr (ed.), Little, Brown & Co., 1992.
63. Gilbert BR, Leslie BR, and Vaughan ED Jr: Normal renal physiology, In: Campbell's Urology, 6th Edition, PC Walsh, AB Retik, TA Stamey, and ED Vaughan Jr (eds). W.B. Saunders, 1992.
64. Vaughan ED Jr, and Sosa RE: Renovascular hypertension, Chapter 55, In: Campbell's Urology, 6th Edition, PC Walsh, AB Retik, TA Stamey, and ED Vaughan Jr (eds). W.B. Saunders, 1992.
65. Vaughan ED Jr and Blumenfeld JD: The adrenals, Chapter 64, In: Campbell's Urology, 6th Edition, PC Walsh, AB Retik, TA Stamey, and ED Vaughan Jr (eds). W.B. Saunders, 1992.
66. Gilbert BR, and Vaughan ED Jr: Renal physiology, Chapter 3, In: Practice of Urology, BS Stein, A Smith, A Caldamone (eds.). Norton Medical Books., Vol. 1, 1992, (pp 1-23).
67. Vaughan ED Jr, and Sosa RE: Renovascular hypertension, In: Current Therapy in Genitourinary Surgery, Kursh Resnick (ed), Mosby-Year Book, Inc., 1992, (pp 487-493).
68. The Proscar Study Group, Vaughan ED Jr, Stoner E, Grino PB, and Guess H: 5 alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia, In: Reproductive Issues and the Aging Male, FP Haseletine, CA Paulsen, C Wang (eds). Em-bryonics Inc.: New York, 1992.
69. Vaughan ED Jr: Pharmacologic treatment of benign prostatic hyperplasia: The use of 5-reductase inhibitors, In: Contem-porary BPH Management, P Puppo (ed.). Monduzzi Editore: Bologna, 1993, (pp. 59-64).
70. Sosa RE, and Vaughan ED Jr: Renovascular and renal parenchymal hypertension, In: Clinical Urology, RJ Krane, MB Si-roky, JM Fitzpatrick (eds.). J.B. Lippincott Co.: Philadelphia, 1994, (pp. 303-113).
71. Vaughan ED Jr: Pheochromocytoma, In: Current Urologic Therapy, 3rd Edition. EJ Seidmon, PM Hanno (eds.). W.B. Saunders: Philadelphia, 1994, (pp. 13-15).
72. Vaughan ED Jr: Primary reninoma of the kidney, In: Current Urologic Therapy, 3rd Edition. EJ Seidmon, PM Hanno (eds.). W.B. Saunders: Philadelphia, 1994, (pp. 118).
73. Vaughan ED Jr: Pathophysiology of renovascular hypertension, Chap. 106, In: Vascular Surgery, 4th Edition. RB Ruther-ford (ed.). W.B. Saunders: Philadelphia, 1994, (Vol. II, pp. 1377-1390.
74. Vaughan ED Jr, and Sosa RE: Hypertension and hydronephrosis, In: Hypertension: Pathophysiology, Diagnosis and Man-agement, 2nd Edition. JH Laragh, and BM Brenner (eds.). Raven Press:New York, Vol. 2, 1995, (pp. 2103-2110).
75. Sosa RE and Vaughan ED Jr: Renovascular hypertension, Chapter 44, In: Smith's General Urology, 14th Edition. AE Tana-gho, JW McAninch (eds.). Lange Medical Publications, 1995, pp. 728-738.
76. Vaughan ED Jr: Tumors of the adrenal cortex, In: Current Surgical Therapy, 5th Edition. JL Cameron (ed.). Mosby-Year Book Inc., pp. 500-506, 1995.
77. Sosa RE and Vaughan ED Jr: Renovascular hypertension, Chapter 23, In: Adult and Pediatric Urology, 3rd Edition. JY Gillenwater, JT Grayhack, SS Howards, JW Duckett (eds.). Mosby - Year Book, Inc., 1996, Vol. 2, pp. 1069-1098.
78. Vaughan ED Jr: Adrenal surgery, Chapter 24, In: Textbook of Operative Urology. FF Marshall (Ed.). W.B. Saunders Co.: Philadelphia, 1996.
79. Vaughan ED Jr.: Catecholamine cardiomyopathy. In: Clinical and Experimental Pheochromocytoma, Second Edition. WM Manger, RW Gifford Jr. Blackwell Science Publications: Cambridge. Chap. 8, pp. 421-422, 1996.
80. Buda AJ, Caprioli J, Clayton PJ, Frank MM, Giudice LJ, Gonzalez E, Rosen S, Shader RS and Vaughan ED Jr: The Com-plete Guide to Pills, B Adderly (Editor). Ballantine Books: New York, 1996.
81. Razvi H, Sosa RE and Vaughan ED Jr.: Endourologic management of complications of urinary-intestinal diversions, In: Textbook of Endourology, RE Sosa, DM Albala, AD Jenkins, AP Perlmutter (Eds.). W.B. Saunders Co: Philadelphia, pp. 188-194, 1996.
82. Vaughan ED Jr: Adrenal tumors, Chapter 9 In: Urologic Oncology, JP Richie, JE Oesterling (Eds.). W.B. Saunders Co.; Philadelphia, pp. 103-122, 1997.
83. Abbou C-C, Allona-Almagro A, Boccon-Gibod L, Fourcroy J, Gillenwater JY, Hoeltl W, Homma Y, Khoury S, McLeod DG, Nyberg LM, Rübben H, Vaughan ED Jr, (Chairman: Roehrborn CG): BPH: Clinical Research Criteria - Report of Committee No. 9. 4th International Consultation on BPH, Paris, France, July 2-5, pp. 439-491, 1997.
84. Blumenfeld JD and Vaughan ED Jr: Renal physiology, Chapter 7 In: Campbells Urology, 7th Edition. PC Walsh, AB Retik, TA Stamey, and ED Vaughan Jr (Eds.). W.B. Saunders Co.:Philadelphia, pp. 263-313, 1998.
85. Gulmi FA, Felsen D and Vaughan ED Jr: Pathophysiology of urinary tract obstruction, Chapter 9 In: Campbells Urology, 7th Edition. PC Walsh, AB Retik, TA Stamey, and ED Vaughan Jr (Eds.). W.B. Saunders Co.:Philadelphia, pp. 342-385, 1998.
86. Vaughan ED Jr and Blumenfeld JD: The Adrenals, Chapter 96 In: Campbells Urology, 7th Edition. PC Walsh, AB Retik, TA Stamey, and ED Vaughan Jr (Eds.). W.B. Saunders Co.:Philadelphia, pp. 2915, 1998.
87. Vaughan ED Jr and Sosa RE: Renovascular hypertension, Chapter 11 In: Campbells Urology, 7th Edition. PC Walsh, AB Retik, TA Stamey, and ED Vaughan Jr (Eds.). W.B. Saunders Co.:Philadelphia, pp. 423-459, 1998.
88. Eid JF and Vaughan ED Jr: Anatomy guidelines and considerations in approaches to renal surgery, In: Atlas of the Urologic Clinics of North America, Open Surgery of the Kidney, Droller MJ (Ed.). W.B. Saunders Co: Philadelphia, Vol. 6, No. 1, pp. 1-24, 1998.
92. Vaughan ED Jr: Forward, In: Shared Care for Prostatic Diseases, R Kirby, J Fitzpatrick, M Kirby, A Fitzpatrick. Isis Medi-cal Media Ltd.: Oxford, in press.
93. Uzzo RG and Vaughan ED Jr: Regulation of renal blood flow, In: Genitourinary Surgery, HN Whitfield (ed.). Blackwell Scientific Publications Limited: London.
94. Gulmi FA, Felsen D and Vaughan ED Jr: The pathophysiology of obstruction: Role of novel vasoactive compounds, In: Genitourinary Surgery, HN Whitfield (ed.). Blackwell Scientific Publications Limited: London..
95. Gilbert BR and Vaughan ED Jr: Renal physiology, In: Clinical Urologic Practice, BS Stein (ed.). Norton Medical Books: New York.
96. Vaughan ED Jr: Foreword, In: The Bladder, JM Fitzpatrik and RJ Krane (eds.). Churchill Livingstone: New York.
97. Vaughan ED Jr.: Forward, In: Textbook of Endourology, R.E. Sosa (Ed.). W.B. Saunders Co. (In press).
98. Vaughan ED Jr: Adrenalectomy, Chapter In: Operative Urology, RJ Krane, J Fitzpatrick, MB Siroky (Eds.). Churchill Liv-ingstone, 1997 (In press).
99. Blumenfeld JD and Vaughan ED Jr: Hypertensive adrenal disorders, In: Therapy in Nephrology and Hypertension, Brady H and Wilcox CS (Eds.). W. B. Saunders (In press).
100. Vaughan ED Jr: Forward, In: Sexual and Reproductive Neurorehabilitation, M Aisen (Ed.). Humana Press, Inc, 1997.
101. Schulsinger DA, Gross SS, Vaughan ED Jr: Role of the NO system in urinary tract obstruction, Chapter 23 in: Nitric Oxide and the Kidney - Physiology and Pathophysiology, MS Goligorsky and SS Gross (Eds.). Chapman & Hall: New York, pp. 443, 1997.
102. Vaughan ED Jr, Schlegel PN, Perlmutter AP: Clinicians Manual on Prostate Specific Antigen. Current Medicine Inc., Phila-delphia, 1998.
103. Vaughan ED Jr (Comments), In: Atlas of Urologic Surgery, F Hinman Jr (ed.). W.B. Saunders: Philadelphia, 1998, (p. 415 and 927).
104. Vaughan ED Jr: Complications of Adrenal Surgery, In: Complications of Urologic Surgery, 3rd Edition. SS Taneja, RM Ehr-lich and RB Smith (Eds.). W.B. Saunders Co. 2000, (Chapter 30, p. 362-369)
105. Vaughan ED Jr, Gulmi FA, Felsen D: Obstructive Nephropathy, In: Medical Management of Kidney and Electrolyte Disor-ders. (In Press)
106. Sosa RE, Vaughan ED Jr: Renovascular Hypertension, In: Smiths General Urology, 15th Edition. E.A. Tanagho, J.W. McAn-inch (Eds.) 1999, (Chapter 45, p. 737 and 749).
107. Vaughan ED Jr, Perlmutter AP: Benign Prostatic Hyperplasia, In: Conns. Current Therapy, W.B. Saunders Co. Philadelphia, 2000, (p. 687 and 691).
108. Vaughan ED Jr. Benign Prostatic Hyperplasia, In: Fast Facts Urology Highlights 1999 2000, J.Shah (Ed.). Health Press, Oxford, 2000, (p. 33 and 39) (In Press)
109. Vaughan ED Jr. Adrenalectomy, In: Operative Urology: Surgical Skills, RJ Krane, MB Siroky, JM Fitzpatrick (Eds.) Chur-chill Livingstone, 2000, (Chapter 1, p. 1-10).
110. Vaughan ED Jr., Complications of Adrenal Surgery, In: Complications of Urologic Surgery: Prevention and Management, 3rd Edition, W. B. Saunders Co., 2001, (Chapter 30, p. 362-369).
111. Schlegel PN, Girardi SK, Vaughan ED Jr. Cancer of the Prostate, In: Surgical Oncology: Contemporary Principles & Prac-tice, C Karakousis (Ed.). McGraw-Hill, 2001, (Chapter 17D, p. 813-839).
112. Vaughan ED Jr: Laparosopic Approach to Adrenal Carcinoma, Endourological Oncology for the Journal of Endourology, submitted, 2000.
113. Sosa RE, Vaughan ED Jr: Renovascular Hypertension and Ischemic Nephropathy, In: Update, (Chapter 23) 2001.
114. Vaughan ED Jr., Gulmi FA, Felsen D. Obstructive Neuropathy, In: Medical Management of Kidney and Electrolyte Disor-ders, CJ Gennari (Ed.), Marcel Dekker, Inc., 2001, (Chapter 23, p. 425-446).
115. Vaughan ED Jr., Foreward, In: Comprehensive Urology, RM Weiss, NJR George, PH OReilly (Eds.) Mosby, 2001.
116. Resnick M., Ackermann R, Bosch J, Cidre J, Foo K, Frank I, Koyanagi T, Palmtag H, Price D, Wallancien G, Vaughan ED Jr., Wein A. Initial Evaluation of LUTS, In: Benign Prostatic Hyperplasia, C Chatelain, L Denis, KT Foo, S Khoury, J McConnell (Eds.) Health Publication Ltd 2001, (Chapter 5, p. 167-199).
117. Vaughan ED Jr. Disorders of the Adrenal Glands, In: Clinical Manual of Urology, PM Hanno, SB Malkowicz, AJ Wein (Eds.) McGraw Hill, 2001, (Chapter 24, p. 709-725).
118. Vaughan ED Jr., Sosa RE. Renovascular Hypertension and Ischemic Nephropathy, In: Adult and Pediatric Urology 4th Ed., Gillenwater JY, Grayhack JT, Howards SS, Mitchell ME (Eds.) Lippincott Williams & Wilkins 2002, (Chap 23, p.973-998).
119. Hinman F Jr., Gillenwater JY, Vaughan ED Jr. Evolution of Research Support in the AUA, In:_History of Urology, 2002__ (Chap 16, p. 721-743).
120. Blumenfeld JD, Vaughan ED, Jr. Renal Physiology and Pathophysiology, Chapter 6, In: Campbells Urology, 8th Edition. PC Walsh, AB Retik, ED Vaughan Jr., Wein AJ (Eds.). W.B. Saunders Co.: Philadelphia, pp. 169-227,2002.
121. Gulmi FA, Felsen D, Vaughan ED Jr. Pathophysiology of Urinary Tract Obstruction, Chapter 12, In: Campbells Urology, 8th Edition. PC Walsh, AB Retik, ED Vaughan Jr., Wein AJ (Eds.). W. B. Saunders Co.: Philadelphia, pp. 411-462, 2002.
122. Vaughan ED Jr., Blumenfeld JD, Del Pizzo J, Schichman SJ, Sosa RE. The Adrenals, Chapter 101, In: Campbells Urology, 8th Edition. PC Walsh, AB Retik, ED Vaughan Jr., Wein AJ (Eds.) W.B. Saunders Co.: Philadelphia, pp. 3507-3569, 2002.
123. Teeger S, Papanicolaou N, Vaughan ED Jr. Imaging of Adrenal Masses, In: Renal & Adrenal Tumors, A Belldegrun, A Ritchie, R Figlin, R Oliver, ED Vaughan Jr. (Eds.) Oxford University Press, 2003, (Chapter 49, pp. 479-485).
124. Blumenthal J, Vaughan ED Jr. Diagnosis and Treatment of Primary Aldosteronism, In: Renal & Adrenal Tumors, A Bellde-grun, A Ritchie, R Figlin, R Oliver, ED Vaughan Jr. (Eds.) Oxford University Press, 2003, (Chapter 52, pp. 536-542).
125. Vaughan ED Jr. Open Adrenalectomy: Indications and Surgical Options, In: Renal & Adrenal Tumors, A Belldegrun, A Ritchie, R Figlin, R Oliver, ED Vaughan Jr. (Eds.) Oxford University Press, 2003, (Chapter 57, pp. 574-580).
126. Shichman S, Sosa RE, Vaughan ED Jr. Lateral Transperitoneal Laparoscopic Adrenalectomy, In: Renal & Adrenal Tumors, A Belldegrun, A Ritchie, R Figlin, R Oliver, ED Vaughan Jr. (Eds.) Oxford University Press, 2003, (Chapter 59, pp. 585-590).
127. Schulsinger DA, Sosa RE, Perlmutter AP, Vaughan ED Jr. Acute and Chronic Interstitial Cryotherapy of the Adrenal, In: Re-nal & Adrenal Tumors, A Belldegrun, A Ritchie, R Figlin, R Oliver, ED Vaughan Jr. (Eds.) Oxford University Press, 2003, (Chapter 62, pp. 603-607).
128. Scardino PT, Abbas F, Adolfson J, Bolla M, Flam T, Naito S, Prezioso D, Shipley W, Solsona Narbon E, Thuroff D, Vaughan ED Jr., Wirth M. Management of Localized Regional Diseases, In: Prostate Cancer, L. Denis, G Bartsch, S Khoury, M Murai, A Partin (Eds.) Health Publications, 2003, (Committee 6, pp. 219-247).
129. Vaughan ED Jr. Diseases of the adrenal gland, In: Medical Clinics of North America, M Resnick (Ed) Elsevier Saunders, 2004, (Chapter 88, pp. 443-466).
Films and Video Tapes
1. Transluminal Renal Angioplasty - E. Darracott Vaughan, Jr., and Thomas A. Sos - 1984.
2. The Effect of High Energy Shock-Waves on Renal Calculus - E. Darracott Vaughan, Jr., William P. Fair and Robert A Riehle, Jr. - 1985.
3. Modification of the Posterior Approach for Right Adrenalectomy - E. Darracott Vaughan, Jr. - 1985.
4. Balloon Dilatation on the Prostate - E. Darracott Vaughan, Jr. - 1990.
Recordings
1. Sosa RE, and Vaughan ED Jr: Diagnosis and treatment of patients with Cushing's Syndrome, 1986.
2. Sosa RE, and Vaughan ED Jr: Diagosis and management of patients with pheochromocytoma, 1986.
3. Sosa RE, and Vaughan ED Jr: Evaluation and treatment of primary hyperaldosteronism, 1986.
Editorships
1. Vaughan ED Jr, and Peach MJ: (Sar1-Ala8) Angiotensin II Saralasin. Kidney International, Vol. 15, 1979.
2. Vaughan ED Jr, and Felsen D: Urologic Pharmacology - Part I. Seminars in Urology, Vol. 2, #3, 1985.
3. Vaughan ED Jr, and Felsen D: Urologic Pharmacology - Part II. Seminars in Urology, Vol. 2, #4, 1985.
4. Vaughan ED Jr: The Ureter. Seminars in Urology, Vol. 5, #3, 1987.
5. ED Vaughan Jr, and RM Carey: Adrenal Disorders, Thieme Medical Publishers, Inc: New York, 1989.
6. Walsh PC, Retik AB, Stamey TA, and Vaughan ED Jr: Campbell's Urology, Sixth Edition, Vols. 1-3, 1992.
7. Romas NA, and Vaughan ED Jr: Alternate Methods in the Treatment of Benign Prostatic Hyperplasia. Springer-Verlag: Ber-lin Heidelberg New York, 1993.
8. Walsh PC, Retik AB, Vaughan ED Jr., and Wein AJ: Campbells Urology, Seventh Edition, Vols. 1-3, 1998.
9. Vaughan ED Jr. and Perlmutter AP: Atlas of Clinical Urology, Series Edition, Current Medicine Inc. Philadelphia, Vol. I. Impotence ☀愀洀瀀㬀 䤀渀昀攀爀琀椀氀椀琀礀 愀渀搀 嘀漀氀⸀ 䤀䤀⸀ 阀 吀栀攀 倀爀漀猀琀愀琀攀Ⰰ 㤀㤀㤀⸀㰀戀爀⼀㸀 ⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䐀椀愀最渀漀猀椀猀 愀渀搀 吀爀攀愀琀洀攀渀琀 漀昀 䄀搀爀攀渀愀氀 䐀椀猀漀爀搀攀爀猀Ⰰ 圀漀爀氀搀 䨀漀甀爀渀愀氀 漀昀 唀爀漀氀漀最礀Ⰰ 匀瀀爀椀渀最攀爀 嘀攀爀氀愀最Ⰰ 开开开开嘀漀氀⸀ ⌀ 㤀㤀㤀⸀㰀戀爀⼀㸀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 刀攀渀愀氀 䴀攀搀椀挀椀渀攀 愀渀搀 刀攀渀愀氀 吀爀愀渀猀瀀氀愀渀琀愀琀椀漀渀 䌀甀爀爀攀渀琀 伀瀀椀渀椀漀渀 椀渀 唀爀漀氀漀最礀Ⰰ 刀愀瀀椀搀 匀挀椀⸀ 倀甀戀氀椀猀栀攀爀Ⰰ 嘀漀氀⸀ 㤀Ⰰ 一漀 ㈀Ⰰ 㤀㤀㤀⸀㰀戀爀⼀㸀㈀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀嘀愀甀最栀愀渀 䔀䐀 䨀爀⸀Ⰰ 倀攀爀氀洀甀琀琀攀爀 䄀倀㨀 䄀琀氀愀猀 漀昀 䌀氀椀渀椀挀愀氀 唀爀漀氀漀最礀Ⰰ 匀攀爀椀攀猀 䔀搀椀琀椀漀渀Ⰰ 䌀甀爀爀攀渀琀 䴀攀搀椀挀椀渀攀 䤀渀挀⸀Ⰰ 倀栀椀氀愀搀攀氀瀀栀椀愀Ⰰ 嘀漀氀⸀ 䤀䤀䤀 吀栀攀 䬀椀搀渀攀礀 愀渀搀 䄀搀爀攀渀愀氀猀Ⰰ ㈀ ⸀㰀戀爀⼀㸀㌀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 䬀椀搀渀攀礀 䐀椀猀攀愀猀攀Ⰰ 䌀甀爀爀攀渀琀 唀爀漀氀漀最礀 刀攀瀀漀爀琀猀Ⰰ 䌀甀爀爀攀渀琀 匀挀椀攀渀挀攀Ⰰ 䤀渀挀⸀Ⰰ 嘀漀氀⸀ ㈀Ⰰ ⌀Ⰰ ㈀ ⸀㰀戀爀⼀㸀㐀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀嘀愀甀最栀愀渀 䔀䐀 䨀爀㨀 匀攀挀琀椀漀渀 䔀搀椀琀漀爀 䄀搀爀攀渀愀氀 䐀椀猀攀愀猀攀猀Ⰰ 䌀甀爀爀攀渀琀 唀爀漀氀漀最礀 刀攀瀀漀爀琀猀Ⰰ 䔀搀⸀ 匀⸀䄀⸀ 䬀愀瀀氀愀渀Ⰰ 䌀刀 䌀栀愀瀀瀀氀攀Ⰰ 䌀甀爀爀攀渀琀 匀挀椀 䤀渀挀Ⰰ 倀栀椀氀愀搀攀氀瀀栀椀愀Ⰰ ㈀ ⸀㰀戀爀⼀㸀㔀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀嘀愀甀最栀愀渀 䔀䐀 䨀爀⸀Ⰰ 䈀愀爀琀猀挀栀 䜀㨀 䬀攀礀 䌀氀椀渀椀挀愀氀 吀爀椀愀氀猀 椀渀 䈀倀䠀Ⰰ 䈀氀愀搀漀渀 䴀攀搀椀挀愀氀 倀甀戀氀椀猀栀椀渀最Ⰰ 伀砀昀漀爀搀Ⰰ 唀䬀Ⰰ ㈀ ㈀⸀㰀戀爀⼀㸀㘀⸀☀渀戀猀瀀㬀☀渀戀猀瀀㬀☀渀戀猀瀀㬀圀愀氀猀栀 倀䌀Ⰰ 刀攀琀椀欀 䄀䈀Ⰰ 嘀愀甀最栀愀渀 䔀䐀 䨀爀⸀Ⰰ 圀攀椀渀 䄀䨀㨀 䌀愀洀瀀戀攀氀氀鈀猀 唀爀漀氀漀最礀Ⰰ 䔀椀最栀琀栀 䔀搀椀琀椀漀渀Ⰰ 嘀漀氀猀⸀ ⴀ㐀Ⰰ ㈀ ㈀⸀㰀戀爀⼀㸀㜀⸀☀渀戀猀瀀㬀☀渀戀猀; Belldegren A, Ritchie A, Figlin RA, Oliver R, Vaughan ED Jr: Renal & Adrenal Tumors, Oxford University Press, 2003.
18. Vaughan ED Jr., Perlmutter AP: Atlas of Clinical Urology, Series Edition, Current Medicine Inc. Philadelphia, Vol. IV Pedi-atric Urology, 2003.
19. Vaughan ED Jr.: BJU International, Blackwell , Vol. 94, 2004.
Audiotapes
Moderator, Counterpoints in Urology Audiotape Series:
- Transrectal Ultrasonography Screening for Prostate Cancer
- Surgical vs. Non-Surgical Approaches to Impotence
- Controversies and Advances in ESWL: 1988
- Intravesical Therapy for Superficial Bladder Cancer
- Management of Renal Cell Carcinoma: Partial vs. Total Nephrectomy
- Observtion Protocol vs. Limited Node Dissection in Testicular Cancer
- Pediatric Varicocele: To Treat or Not to Treat
- Ureteroscopy: Rigid vs. Flexible
- Urinary Incontinence: Medical vs. Surgical Management
- Balloon Dilation of the Prostate vs. Traditional Approaches to BPH
- Extracorporeal Shockwave Lithotripsy vs. Percutaneous Nephrolithotomy for Renal Stone Removal
- Carcinoma of the Prostate: Total Oblation vs. Traditional Therapy
- Carcinoma of the Prostate: External Beam Radiation vs. Radical Surgery
- Prostate Specific Antigen (PSA): To Screen or Not
- Carcinoma of the Prostate: Laparotomy vs. Laparoscopy for Pelvic Lymphadenectomy
- Physicians Practice Update Program: Urology
Conversations
Jack W. McAninch: BJU International 94:251-252, 2004.
